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Expression, Purification and Characterization of Enzymes  
Involved in the Activation of Aromatic Ring Compounds in Aspergillus niger 
Justin Raiche-Moyyen 
 In microbial degradation of hydroxy-aromatic compounds, preparation of the ring for 
cleavage is a crucial step.  Two enzymes types involved in this are hydroxylases  and 
decarboxylases.  Hydroxylases introduce an oxygen atom into the aromatic ring while 
decarboxylases remove a carboxyl group.  Bacteria and fungi are known to elaborate these types 
of enzymes but fungal forms have so-far received relatively little attention.  
 A. niger is a fungus which has been shown previously to grow on salicylate, benzoate, 
and several other aromatics
1
.  The A. niger genome has many genes annotated as coding for 
aromatic hydroxylases and some decarboxylases: fifteen such genes were chosen for 
recombinant expression in E. coli.  Of these, four corresponding hydroxylases were successfully 
expressed, purified, and characterized according to substrate specificity, cofactor requirement 
and quaternary structure.  These proteins, all FAD-containing, comprise a true salicylate 
hydroxylase, two salicylate hydroxylase-like enzymes, and a hydroxylase active on p-cresol, 
resorcinol, and hydroquinone.  While the first enzyme is likely to be involved in metabolism of 
salicylate, the functions of the two salicylate hydroxylase-like enzymes are unclear, as is the 
function of the p-cresol active enzyme.  A fifth enzyme, 2,3-dihydroxybenzoate decarboxylase, 
was also successfully expressed in E. coli and purified.  Although its properties were similar to 
those previously reported for the enzyme isolated from A. niger 
2,3,4
, the pH optimum appeared to 
be somewhat higher. In addition, it was found that this enzyme could catalyze the reverse 
reaction, carboxylation of catechol, and that after treatment with a mixture of chelators Ca
2+
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 Aromatic compounds constitute a large percentage of the Earth's biomass, mainly as the 
building blocks of lignin, the second most abundant plant biopolymer.  Although aromatic 
compounds in central metabolism are mainly limited to a few amino acids and their derivatives, 
plants produce large quantities of secondary metabolites containing diverse aromatic rings.  
Aromatics are also found in large quantities in petroleum, and are produced and manufactured 
for industrial uses.  In general, aromatic compounds are toxic to mammals, which have a 
relatively limited ability to degrade them.  Instead mammals attempt to detoxify aromatic 
compounds and excrete them. 
 By contrast, many microorganisms have evolved to degrade aromatic compounds 
available in nature by channelling them into central metabolic processes, such as glycolysis and 
the TCA cycle, to capture energy in the form of ATP.  Some have even been reported to break 
down compounds which have been synthesized: an example is pentachlorophenol degradation by 
Sphingomonas chlorophenolica
5
.  A few examples of naturally-occurring compounds commonly 
broken down by both bacterial and fungal species are monocylic aromatics such as benzoate, 
salicylate, and phenol
6,7
. (Fig.1.1).  Although these compounds are naturally-occurring, industrial 
use can dramatically increase their presence in the environment.  Chloro- and nitro-substituted 
versions of these three simple aromatics can also be degraded by some bacterial species: for 
example, 4-chlorophenol or 2-chloro-4-nitrophenol are broken down by Burkholderia sp. RKJ 
800
8
.  Polycyclic aromatic compounds such as biphenyl, chlorobiphenyls, and naphthalene (Fig. 
1.1),  have also been reported to be degraded by bacteria
9
.  Studying the degradation of aromatic 
compounds by microorganisms is not only of interest to learn about the natural catabolic 
diversity of microbes, but to potentially harness this catabolic power in bioremediation processes 
to decontaminate soil or water from toxic aromatic compounds.   
 Although microbial metabolism of aromatics can occur aerobically or anaerobically, this 









Benzoate Salicylate Phenol Biphenyl Naphthalene
 
Figure 1.1: Structures of aromatic compounds mentioned in the text 
1.1.1 Bacterial degradation strategies for benzoate derivatives 
 Aerobic bacterial aromatic degradation pathways for benzoates have been intensively 
studied and characterized.  In common with other bacterial aromatic catabolic pathways, the key 
steps are: conversion to dihydroxylated ring-cleavage intermediate; oxygenolytic cleavage of the 
ring; and conversion of the ring-cleavage products into central metabolites.   In the case of 
benzoates, the main ring-cleavage intermediates are catechol, protocatechuate, hydroxyquinol, 
hydroxyquinone, and gentisate, which can all be cleaved by non-heme iron-containing 
dioxygenase enzymes
10
 (Fig. 1.2).  Catechol and protocatechuate can be catabolized via either 
meta or ortho cleavage pathways, which involve dioxygenases that cleave between the hydroxyl 
groups of the ring cleavage substrate, or adjacent to them, respectively (Fig. 1.2).  Via the ortho 
cleavage pathway, catechol, protocatechuate, and hydroxyquinol can be broken down to 
succinyl-CoA and acetyl-CoA to be used in the TCA cycle via the β-ketoadipate pathway.1  By 
contrast, in the meta-cleavage pathways catechol, protocatechuate, and gentisate are all 
converted to pyruvate: in addition, catechol, protocatechuate and gentisate also produce acetyl-
CoA, oxaloacetate and fumarate, respectively.  Finally, hydroxyquinone is converted into the 
central metabolites, succinyl-CoA and acetyl-CoA, via a meta-cleavage pathway to be used in 










































































Figure 1.2: Ring cleavage pathways of microorganisms (Adapted from Vaillancourt et al, 2006
10
)  
 The ring cleavage substrates described above are produced from benzoates by 
combinations of monooxygenase (hydroxylase) catalyzed reactions.  For example, both catechol 
and gentisic acid may be formed from salicylate (2-hydroxybenzoate), via salicylate 
hydroxylase.  Salicylate 1-hydroxylase
11
 produces catechol from salicylate via a 
decarboxylation-hydroxylation reaction, while salicylate 5-hydroxylase
12
 converts salicylate to 
gentisate with only a hydroxylation step.  Salicylate 1-hydroxylase has been identified in 
Pseudomonas putida PpG7
11
, while salicylate 5-hydroxylase has been isolated from Ralstonia 
sp
12
.  Catechol can also be produced via hydroxylation of phenol by phenol hydroxylase which 
has been isolated from, for example, Pseudomonas putida CF600
13
.    Protocatechuic acid is 





.  The formation of both hydroxyquinol and hydroquinone have been observed in 
Candida parapsilosis CBS604.  Hydroxyquinol can be formed by the hydroxylation of either 
hydroquinone or resorcinol by hydroquinone hydroxylase 
15
, while benzoate is decarboxylated 
and hydroxylated  to produce hydroquinone by as-yet unidentified enzymes
16
.  
1.1.2 Fungal degradation strategies for benzoate derivatives  
 The enzymes involved in bacterial aerobic aromatic degradation have been well studied 
and characterized, but relatively little characterization of benzoate-degrading enzymes from 
fungi has taken place.  This is despite the fact that various authors have reported growth of a 
range of fungi and yeast on benzoates and their derivatives
1
.  One of the exceptions is the soil 
yeast Trichosporon cutaneum, which exhibits considerable diversity in the range of single-ring 
aromatic compounds it can metabolize, including phenol, salicylate, benzoate, 2-3-
dihydroxybenzoate, protocatechuate, and gentisate.  T. cutaneum possesses catechol 1,2-
dioxygenase and hydroxyquinone 1,2-dioxygenases, while it lacks protocatechuate, 2,3-
dihydroxybenzoate or gentisate dioxygenases that are commonly found in bacteria 
17
.  2,3-
Dihydroxybenzoate is first decarboxylated via a 2,3-dihydroxybenzoic acid decarboxylase to 
form catechol, which is cleaved by catechol 1,2-dioxygenase.  Additional hydroxyl groups are 
added to protocatechuate and gentisate, concomitantly with decarboxylation to form 
hydroxyquinol which is cleaved by hydroxyquinol 1,2-dioxygenase dioxygenase.  For benzoate 
degradation, three hydroxylation reactions are catalyzed by T. cutaneum to form 4-
hydroxybenzoate, protocatechuate and, finally, hydroxyquinol which can then be cleaved by 
hydroxyquinol 1,2-dioxygenase.  Neither this organism or any other eukaryote has been reported 




 A filamentous fungus that has been reported to grow on benzoate and some of its 
derivatives is the industrial workhorse and model fungus, Aspergillus niger
1
.  A. niger has been 
shown to grow on many benzoate derivatives, including p-hydroxybenzoate, p-methoxybenzoate, 
protocatechuate, and catechol, as well as lignin building blocks such as vanillate, ferulate, and 
caffeate
1
.  A. niger growth on these substrates indicates there must be aromatic degrading 
enzymes in the A. niger proteome but to date few have been isolated and characterized.  Those 
that have, and which have roles in the preparation of aromatic compounds for ring cleavage, 
5 
 
include a p-hydroxybenzoate hydroxylase
18
, a 2,3-dihydroxybenzoate decarboxylase
2
 and an 
anthranilate hydroxylase
19
 which are, respectively, responsible for benzoate conversion to p-
hydroxybenzoate, 2,3-dihydroxybenzoate decarboxylation to catechol, and anthranilate 
conversion to 2,3-dihydroxybenzoate.  However, in the genome of A. niger the genes encoding 
these enzymes are a small fraction of the genes annotated with functions related to the 
metabolism of benzoates. 
1.1.3 A. niger genes annotated to be involved in aromatic ring degradation 
 The genome of Aspergillus niger was amongst the first published for a filamentous 
fungus
20
.  Since then, many hundreds more have been sequenced.  Currently, the Joint Genome 
Institute's 1000 genome project aims to obtain a  better understanding of fungal diversity by 
sequencing two genomes of every fungal family.
21
  Within all these genomes, some genes have 
previously been characterized while many others are annotated only by bioinformatic 
comparison with known genes.   
 In the A. niger genome many genes are annotated with functions suggesting that they are 
involved in aromatic degradation pathways.  There are two publically-available Aspergillus niger 
genomes, A. niger ATCC 1015v4.0
22
, prepared by the JGI (Joint Genome Institute), and the A. 
niger NRRL3 genome prepared during the Genozymes
23
 project.  The NRRL3
23
 A. niger genome 
has been manually curated and has 65 genes annotated as hydroxylase enzymes.  Of these 65 
genes, almost all have been annotated as either salicylate hydroxylase, phenol hydroxylase, or 
aromatic ring hydroxylase enzymes.  Although, as described above, A. niger has been shown to 
grow on benzoate and salicylate, no experimental evidence that A. niger grows on phenol has 
been reported. However, Aspergillus fumigatus
24
 and Aspergillus awarmori
25
 have both been 
shown to grow on phenol, so it is possible that A. niger also has this capability. 
 Upon examination, these annotated A. niger hydroxylase gene sequences are often only 
between 20% - 35% identical with characterized bacterial counterparts.  Considering that 
aromatic hydroxylase enzymes encoded by fungal genes have rarely been expressed and 
characterized, and the sequence similarity between the fungal and bacterial versions is often low, 
there could potentially be some major differences in the properties of the enzymes they encode 
that reflect different lifestyles of bacteria and fungi.  Bacteria are prokaryotic single-celled 
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organisms while fungi are eukaryotic multi-cellular organisms.  Bacteria and fungi can live in the 
same environments, but they can also live under quite different conditions.  For example A. niger 
has been reported to grow at temperatures ranging from 6-47 
o
C and at pH values from 1.4-9.8
26
. 
A. niger is a useful model fungus for studying aromatic degradation because in addition to 
having a fully sequenced and annotated genome, it is known to grow on aromatic substrates as 
sole carbon sources, and it has also been used in many other areas of research and in industrial 
applications. 
1.1.4 Properties of monooxygenase (hydroxylase) enzymes for hydroxyaromatics 
 This thesis will mainly focus on fungal enzymes responsible for preparing 
hydroxyaromatics for subsequent ring-cleavage.  Referred to as "monooxygenases" or 
"hydroxylases", these enzymes are responsible for hydroxylating aromatic rings with one (or 
sometimes more) OH group by inserting one atom of molecular oxygen into the ring and 
reducing the other to water (reviewed in Huijers et al, 2014
27
).  The electron-donating OH group 
makes it easier for the ring to be broken open in the next metabolic step by ring-cleaving 
dioxygenase enzymes.  In order for hydroxylation to occur, in addition to the aromatic substrate 
most of these monooxygenase require FAD and NAD(P)H cofactors.  NAD(P)H is a dissociable 
cofactor responsible for reducing the enzyme-bound FAD to its FADH2 state, which can react 
with O2.  The structures of FAD-containing aromatic hydroxylases generally are mixed α-helical 
and  β-sheet-containing proteins with a substrate binding site in addition to the FAD and 
NAD(P)H binding sites.  FAD and NADH are dinucleotide cofactors whose binding sites are 
located in the Rossmann fold domain which is a classical β-α-β motif28. As an example, the 
structure of a bacterial salicylate hydroxylase from Pseudomonas putida is displayed below: the 






Figure 1.3: Crystal structure of salicylate hydroxylase from Pseudomonas putida (PDBID: 
5evy)
28
 generated using PyMOL. 
 O2 activation by FADH2 to hydroxylate aromatic substrates is tightly coupled if all of the 
oxygen consumed is used for hydroxylation.  However, there can be hydrogen peroxide by-
product formed with these enzymes when oxygen is not completely used for hydroxylation of the 
aromatic ring.  This is referred to as "oxygen uncoupling"
29
.  In order to understand this 
phenomenon, the mechanism of these enzymes must be considered (Fig. 1.4).  The first step is 
the reduction of FAD to FADH2 using the electrons donated from NAD(P)H as the reducing 
power.  The second step consists of O2 reacting with the reduced flavin to form the C4a-
flavinhydroperoxide.  Lastly, this C4a-flavinhydroperoxide intermediate transfers its terminal 
oxygen to the aromatic ring substrate, and the other atom remains with the flavin as a C4a-flavin 
hydroxide which eliminates water to regenerate FAD (reviewed in Ballou et al, 2005)
30
. Oxygen 
uncoupling occurs when FAD is reduced and the C4a-hydroperoxide is formed, either when the 































Figure 1.4: Salicylate 1-hydroxylase mechanism. The symbol (:B) is a catalytic base.   
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 Usually, oxygen uncoupling with no substrate is low since flavin reduction is quite slow 
in the absence of aromatic substrate bound to the enzyme
30
.  However it is possible for some 
flavoprotein hydroxylases to recognize a pseudo-substrate, which binds similarly to the true 
substrate, stimulates FAD reduction, but is not hydroxylated at all, resulting in complete 
diversion of oxygen to H2O2.  This was first reported for a salicylate hydroxylase isolated from 
Pseudomonas putida by White-Stevens et al. (1972), where benzoate is a non-substrate effector 
that causes formation of H2O2 while it's true substrate salicylate is fully coupled.  They also 
observed partial hydroxylation of some substrates such as 3-methylsalicylate, 2,4-
dihydroxybenzoate, and 2,5-dihydroxybenzote.
29
  Partial hydroxylation occurs when a non-
optimal but catalytically-competent substrate is bound and decay of the C4a-flavin 
hydroperoxide competes with hydroxylation.  In addition, it has been shown that in other 




1.1.5 Aromatic monooxygenases from fungi 
 In the literature, there are many bacterial aromatic ring hydroxylases, like the salicylate 
hydroxylase described above, that have been identified and studied, but far fewer from fungi 
have been reported.  Previous studies have shown that fungal monooxygenases are active on 
benzoate and many of its derivatives such as 4-hydroxybenzoate, 3-hydroxybenzoate, phenol, 
and salicylate (reviewed in Wright et al
7
).  In many cases, crude extracts of these fungi were used 
to assay the activities of these enzymes, but the  specific enzymes were not purified or isolated.  
For example, some fungi have been reported to be able to degrade benzoate.  Benzoate 
hydroxylase activity, converting benzoate to 4-hydroxybenzoate, has been reported for 
Aspergillus niger, Rhodotorula graminis and Trichosporon cutaneum
7
.  4-Hydroxybenzoate 3-
monooxygenase activity has been observed in extracts of A. niger, Penicillium spinulosum, 
Schizopyllum commune, and Penicillium sp., Aureobasidium pullulans, Neurosporacrassa, 
Rhodotorula mucilaginosa, Trichoderma viride which converts 4-hydroxybenzoate to 
protocatechuate (3,4- dihydroxybenzoate).
7
  In A. niger it was also reported that 3-
hydroxybenzoate could be converted to protocatechuate via a 3-hydroxybenzoate-4- 






 Salicylate hydroxylase is an enzyme of interest since it is involved in transforming 
salicylate, a very important bio-molecule especially in plants and fungi.  In fact, salicylate is 
involved in the plant immune response and it is theorized that the salicylate hydroxylase 
expressed in some symbiotic fungi such as Epichole festucae is responsible for drawing out the 
host plant defence by breaking down salicylate.
33
   
 Salicylate hydroxylases are probably the most well studied flavoprotein hydroxylase 
enzymes from fungi, and enzymes from different species produce a variety of products (Fig. 1.5).  
Some have been observed to decarboxylate and hydroxylate salicylate to form catechol as is the 




, and Epichloe festucae
33
.  However, 
others have also been observed to simply hydroxylate with no decarboxylation.  This can 
involve: salicylate conversion to 2,4-dihydoxybenzoate, as observed in A. niger, A. nidulans, and 
Trichosporon sp.; salicylate conversion to 2,5-dihydroxybenzoate observed in Trichosporon sp.; 
or conversion of salicylate into 2,3-dihydroxybenzoic acid as in A. niger, A. nidulans, and 
Trichoderma lignorum.
7
   
 
Figure 1.5: Diversity of products formed by salicylate hydroxylase from various microorganisms 
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 Some fungi have been reported to degrade phenol
24,25
.  Phenol hydroxylase has been 
identified and isolated from Trichosporon cutaneum, and shown to transform phenol into 
catechol
35
.  Phenol is a common industrial by-product, and is highly toxic and can cause many 
undesired effects in humans when consumed
36
.  At high levels phenol can even be lethal and 
phenol has also been classified as a potential mutagen and carcinogen
37
.  Its mineralization by 
microbes is potentially of interest for bioremediation purposes.  
1.1.6 (Di)-Hydroxybenzoate decarboxylases 
 Monooxygenases are the main type of enzyme responsible for converting aromatic rings 
into ring cleavage substrates, but another class of enzymes which can also perform this task is 
the aromatic ring decarboxylases.  These enzymes remove carboxyl groups on the aromatic ring 
without the use of oxygen, releasing CO2
38
.  For example, 2,3-dihydroxybenzoate 
decarboxylation to catechol is catalyzed by 2,3-dihydroxybenzoate decarboxylase (Fig. 1.6).  
The proposed mechanism involves initiating the reaction by first forming a quinone via  
deprotonation of the OH group nearest to the carboxyl group.  Due to the resonance 
destabilization of the intermediate, decarboxylation is facilitated and subsequently reprotonated 





















Figure 1.6: 2,3-Dihydroxybenzoate decarboxylase mechanism  
 Usually such aromatic decarboxylases are metal dependent and active on compounds 
which already have hydroxyl groups on the aromatic ring in addition to the carboxyl group.   
However, there have been several reports of aromatic decarboxylases not requiring metals, 
especially amongst those from fungi.  2,6-Dihydroxybenzoate decarboxylases from Rhizobium 
sp
39
, and from Polaromonas sp
40





 respectively.  On the other hand, salicylate decarboxylase and 2,3-
dihydroxybenzoate decarboxylase from Trichosporon moniliiforme
41





respectively, are fungal decarboxylases that have been reported not to require metal ions.  4-





, respectively, are examples of bacterial 
decarboxylases reported not to require metal ions for activity.  Thus, the metal ion requirement, 
and the identity of the metal ion itself, appear to vary from decarboxylase to decarboxylase.   
 A few common elements within this class of enzymes is that they appear to usually be 
tetramers, and have a common TIM-barrel folding motif comprising 8 alternating α,β strands, 
regardless of whether the enzyme has been reported to require a metal ion or not
39
.  These 
decarboxylases usually exhibit very high specificity for one substrate: such is the case for the 
2,3-dihydroxybenzoate decarboxylase from A. niger
2
 which only decarboxylates 2,3-
dihydroxybenzoate. However, there are also examples of enzymes displaying more substrate 
diversity such as the 2,6-dihydroxybenzote decarboxylase from Rhizobium sp.
44
, which 
decarboxylates both 2,6-dihydroxybenzoate and 2,3-dihydroxybenzoate. 
 Many aromatic decarboxylases also have been reported to also catalyze the reverse 
reaction (carboxylation), as has been reported for enzymes such as salicylic acid decarboxylase 
from Trichosporon monilliforme
41
 and 2,6-dihydroxybenzoate decarboxylase from Rhizobium 
sp
45
.  For most of these enzymes, reversibility is affected by oxygen, and usually they require 
reducing agents such as DTT in assays to observe carboxylation in vitro 
41
. 
 Up to this point all the enzymes discussed have been treated as enzymes involved in 
aromatic compound degradation.  Although this has been shown for a large number of these 
enzymes, they may not always be involved in aromatic compound degradation.  For example, 
these types of enzymes could be responsible for forming intermediates in biosynthetic pathways.  
One example is 2,3-dihydroxybenzoate, which could be produced by salicylate 3-hydroxylase 
from salicylate.  2,3-Dihydroxybenzoic acid could be further processed into catechol and fed into 
the β-ketoadipate pathway for degradation, but several molecules of 2,3-dihydroxybenzoate 
could also be combined into siderophores such as enterobactin, anguibactin, and vibriobactin 







1.1.7 Strategies for producing and characterization of fungal enzymes 
 Degradative enzymes may be obtained in two main ways: either extract them from the 
native organism, or express them in recombinant form. In the case of the first method, the 
organism must be grown under appropriate conditions in order to induce the expression of the 
enzymes of interest.  For expression of aromatic degradative enzymes, aromatic compounds that 
can be used directly as sole carbon and energy sources are often used as the growth substrate to 
induce enzymes that are responsible for the breakdown of the carbon source, or responsible for 
their conversion to carbon dioxide and water.  Another option is to use a more complex 
aromatic-containing compound, such as lignin, which can be broken down into benzoate or 
benzoate-like compounds by certain microorganisms.  
 For recombinant expression, the fungal gene is inserted into a plasmid, which is 
transformed into an expression host, such as E. coli, that expresses the enzyme encoded in the 
insert.  There are several challenges to expressing fungal proteins in bacteria.  First, mRNA from 
the fungus, grown under appropriate conditions to induce enzyme expression, must be extracted 
and then reverse transcribed into cDNA in order to be utilized in bacteria.  The reason for this is 
that fungi are eukaryotes that contain introns in their genes.  Higher organisms such as fungi 
have the ability to splice these non-coding DNA fragments out, but bacteria do not.  cDNA must 
therefore be used to have a DNA template that does not contain introns.  If intron-containing 
DNA is used in bacterial protein expression it will result in an abnormal protein containing 
unnecessary amino acid regions, premature stop codons, or frame shifts, and this will usually 
result in inactive enzyme.  It can also be difficult to predict the correct start codon, and 
differences in codon usage can effect expression levels
47
. 
 Although there are challenges to expressing fungal enzymes in E. coli, it has several 
advantages.  E. coli expression plasmids and hosts are well-developed and easy to manipulate.  
E. coli has one of the shortest doubling time of any known organism, only about 20 min.
48
   
Fungi on the other hand have a much longer doubling time on the scale of hours:  Aspergillus 
niger has a doubling time of about 3.6 h.
49
  Fungi can take days to express enough protein to 
work with, while E. coli can produce these desired levels in a matter of hours.  E. coli is a 
biohazard level 1 organism, whereas, A. niger is biohazard level 2.  A. niger in general is fairly 
harmless but in immuno-compromised individuals, such as those allergic to its spores, it can 
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cause harm: in addition some strains can produce toxins.  Expressing A. niger enzymes in E. coli 
eliminates the risk of exposure to A. niger spores and toxins.   
 A possible disadvantage of expressing fungal proteins in bacteria is that the protein 
produced may not be fully native since bacteria do not have as much machinery for protein post-
translational modifications, if any are required.  This becomes an issue in attempting to express 
enzymes which are normally secreted by fungi, since bacteria do not have the same capabilities  
to cleave signal peptides or carry out other important modifications such as glycosylation or 
phosphorylation.  However, the enzymes that are targeted in this thesis are intracellular enzymes 

















1.2 Goals of this work 
 Fungal genome sequencing efforts have resulted in published genomes that are replete 
with genes annotated as being involved in degradation of aromatic compounds, although almost 
no corresponding fungal enzymes have been characterized.  The primary goal of this master's 
project was to identify, express and characterize enzymes, from the model fungus Aspergillus 
niger, that potentially encode enzymes involved in activation of aromatic ring compounds for 
ring cleavage.  Most of the enzyme targets are of the monooxygenase class of enzymes, which 
hydroxylate aromatic rings to form di-hydroxylated single aromatic ring compounds.   These 
enzymes were expressed in E. coli by first choosing genes that are annotated as hydroxylase 
enzymes in the A. niger genome.  The workflow of the project consisted of: cloning genes into 
the pLATE11 E. coli plasmid; expressing them in E. coli; purifying the expressed proteins; and 
then characterizing them to see if they perform their bioinformatically assigned functions, most 
of which are based on weak sequence similarity to bacterial counterparts.  Another goal was 
characterization of these enzymes to identify if there are any differences in their characteristics 
compared to those from bacteria.  In studying these enzymes, we expected to find  some 
properties or structure-function relationships of the fungal enzymes that differ from those of 
bacteria.   
 The long term goal of this project is to eventually combine this work with research on 
other enzymes associated with the degradation of aromatic ring compounds, and map out the 
aromatic degradation pathways in A. niger for  comparison to those already known in bacteria 
and fungi.  In addition, although the goal of this project is to understand these enzymes better, 









2. MATERIALS AND METHODS 
2.1 Gene Selection, Amplification, Purification, and Analysis 
2.1.1 Bioinformatic analysis of the Aspergillus niger genome to identify potential aromatic 
monooxygenases 
Genes were identified by using text such as "monooxygenase", "hydroxylase", and 





genomes prepared by the Joint Genome Institute (JGI) and Concordia Fungal Genomics Project 
respectively. Potential genes of interest were then Blasted against the Uniprot/Swissprot 
database, and those hits having at least 30% sequence identity with the query sequence were 
investigated further. 
2.1.2 PCR primers 
PCR primers were designed for use with the Thermo Scientific aLICicator LIC cloning 
kit following the manufacturer’s recommendations50.  All forward primers began with the 
nucleotides 5'-AGAAGGAGATATAACT-3’, followed by the coding sequence of interest.  For 
reverse primers 5'-GGAGATGGGAAGTCA-3’ was followed by the coding sequence of interest. 
All primers were designed to have a Tm of 60 
o
C or greater, as well as a GC content of 40-
60%
50




















































Table 2.1: Primer Sequences used for Touchdown PCR 
2.1.3 PCR reactions 
 PCR reactions (50 μl) were prepared as indicated in Table 2.2 below.  Genes were 
amplified using Touchdown PCR, using the conditions shown in  Table 2.3 below 
51
.  Template 
DNA used was cDNA prepared by the Centre for Structural and Functional Genomics (CFSG) 
from Aspergillus niger N402 grown on 2 % alfalfa and barley.  The dNTP mixture was 
purchased from Roche, and Phusion High-Fidelity DNA Polymerase was purchased from New 
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England Biolabs (NEB).  PCR reactions were performed using the Applied Biosystems Verti 96 
Well Thermal Cycler. 
Component Volume (μL) 
Nuclease free water 24.0 
5X Phusion HF or GC 
Buffer 
10.0 
1 mM dNTP's 10.0 
10 μM Forward Primer 2.5 
10 μM Reverse Primer 2.5 
Aspergillus niger cDNA 0.5 
Phusion DNA polymerase 0.5 
Table 2.2: PCR Reaction Components 
Phase Cycles Step Temperature (
o













Elongation 72 120 
2 25 
Denaturation 98 30 
Annealing 67 45 
Elongation 72 120 
Final Extension 1 Final Extension 72 600 
Hold 1 Hold 4 ∞ 
Table 2.3: Touchdown PCR Program 
2.1.4 Analysis and purification of PCR products 
PCR products were prepared in 6X loading dye (ThermoScientific) and subjected to  
electrophoresis on 0.8-1.0 % agarose gels, containing ethidium bromide at 100V for 45-60 min.  
Fermentas Generuler 1kb ladder standards were run simultaneously with all PCR products.  Gels 
were visualized under UV light using a UV illuminator. Bands of interest were excised using a 





2.1.5 Plasmid construction 
 Cloning of purified PCR products into the pLATE 11 vector was performed using the 
Thermo Scientific aLICator Ligation Independent Cloning Expression System
4
, as specified by 
the manufacturer.  1 Unit of T4 DNA Polymerase was used to generate the 5' and 3' overhangs 
on PCR products in a 10 µl reaction volume, and reactions were quenched with EDTA after 5 
min.  The annealing reaction was then performed by adding the pLATE11 vector 
50
. The 
resulting plasmid was then transformed into  E. coli DH5α. 
2.1.6 Transformation of plasmids into E. coli DH5α 
 For transformation, the entire reaction mixture (10 µl) from the previous step was mixed 
with DH5α competent cells (50 µl) and incubated on ice for 30 min.  Cells then underwent 42oC 
heat-shock treatment for 45 sec.  They were then incubated on ice for 2 min followed by growth 
in LB at 37
o
C with 225 rpm shaking for 1 h.  Aliquots were then plated on LB + 100 µg/mL 
carbenicillin plates, and grown overnight (12-16 h) at 37 
o
C (Modified procedure from Current 
Protocols in Molecular Biology, 2003) 
53
. 
2.1.7 Growth of recombinant E. coli cells and plasmid extraction/purification 
 A single colony from the transformation step was inoculated into 5 mL of LB + 100 
µg/mL carbenicillin medium and grown overnight (12-16 h) at 37 
o
C and 225 rpm.  Recombinant 




2.1.8 Plasmid analysis via restriction enzyme digestion 
 Restriction digest analyses were performed using the appropriate NEB, Fermentas, or 
Promega restriction enzymes to cleave plasmids, followed by analysis of the resulting fragments 
by agarose gel electrophoresis.   Restriction digests were performed according to the protocols 
provided by the restriction enzyme manufacturer. In all cases, this involved using 1-10 Units of 
restriction enzyme in the appropriate buffer to cleave 50-150 ng of plasmid DNA.  Expected 
fragment sizes were determined by inputting plasmid and gene sequence into the NEBcutter 
V2.0 server
55




2.1.9 Plasmid analysis via PCR 
Fragment insertion into the cloning vector was also checked by PCR amplification of the 
gene from plasmids using the pLATE11 sequencing primers provided with the Thermo Scientific 
aLICator Ligation Independent Cloning Expression kit.  PCR reactions were set up as indicated 
in Table 2.4 and the PCR program utilized is presented in Table 2.5.  The resulting PCR products 
were then observed via agarose gel electrophoresis using the same procedure as described above.   
Component Volume (μL) 
10X Thermopol Reaction Buffer 2.0 
1mM DNTP's 4.0 
10 μM Forward LIC Sequencing Primer 0.4 
10 μM Reverse LIC Sequencing Primer 0.4 
Plasmid DNA 0.5 
Taq DNA polymerase 0.1 
Nuclease free water 12.6 
Table 2.4: Plasmid Analysis PCR Reaction Components (20 μl) 
Step Temperature (
o 
C) Time (s) Cycles 
Initial denaturation 98 180 1 
Denaturation 98 30 
25 Annealing 58 45 
Elongation 72 120 
Final Elongation 72 600 1 
Hold 4 ∞ 1 
Table 2.5: Plasmid Analysis PCR Program 
2.1.10 Recombinant plasmid analysis via DNA sequencing 
Plasmids were sequenced at the McGill University and Genome Quebec Innovation 
Centre using the pLATE11 forward and reverse sequencing primers provided with the cloning 
kit.  Trimmed sequencing results representing the (reliable portions) of the forward and reverse 
complementary sequences were Blasted against each other to find the overlap region, which was 
deleted.  The remaining sequences were then used to generate the full sequence, which was 
compared to the genomic sequences.  In cases where there appeared to be missing residues at 
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either ends of the sequence the untrimmed sequences were used.  In cases where differences 
were observed the chromatogram was manually interpreted to decide whether the difference was 
real or not. 
2.2 Protein Production, Analysis and Purification 
2.2.1 Transformation of plasmids into E. coli expression strain 
Plasmids (1 µL, of 50-150 ng/μL, depending on the plasmid) were transformed into E. 
coli BL21 DE3
56
 or Rosetta DE3
57
 competent cells (50 µL).  After addition of plasmid, cells 
were placed on ice for 30 min.  Cells then underwent a 42 
o
C heat shock treatment for 45 s, 
followed by growth in LB at 37 
o
C with 225 rpm shaking for 1 h.  Cells were then plated on LB 
+ 100 µg/mL carbenicillin plates for E. coli BL21 DE3, and LB + 100 µg/mL carbenicillin + 30 






2.2.2 Growth of recombinant E. coli cells for protein expression 
Single colonies from fresh transformation plates were inoculated into 5 mL of LB + 100 
µg/mL carbenicillin (+ 30 μg/mL chloramphenicol for Rosetta DE3) medium and grown 
overnight (12-16 h) at 37 
o
C and 225 rpm shaking.  Then 1 mL of overnight culture was added 
for every 100 mL of LB + 100 µg/mL ampicillin (+ 30 μg/mL chloramphenicol for Rosetta DE3) 
medium, and the culture was grown to an OD600 of 0.6.  Protein expression was induced by the 





2.2.3 Harvesting and cell lysis of recombinant E. coli cells 
Cells were pelleted by centrifugation at 8 500 x g at 4 
o
C for 10 min, and the resulting 
supernatant was removed.  Cells were washed by resuspending with 50 mM Tris-HCl pH 7.6 
buffer, followed by pelleting at 8 500 x g for 10 min: supernatant was removed.  Cell pellets 
were then stored at -20 
o
C or used immediately.  For lysis, cell pellets were resuspended in 50 
mM Tris-HCl pH 7.6, at a 2 mL buffer per gram ratio, and sonicated using a Biologics Model 
300 V/T Ultrasonic homogenizer at maximum power for 10 x 10 s, taking 15 s pauses in between 
each 10 s of sonication.  Cell lysate was centrifuged at 40 000 x g for 10 min and supernatant 
(“crude extract”) was retained.   Centrifugation was repeated two more times in order to remove 
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as much cell debris as possible.   Cells were kept on ice or at 4 
o
C at all times during the lysis 
procedure. 
2.2.4 Analysis of proteins via SDS-Electrophoresis (SDS-PAGE) 
Proteins were analyzed via SDS-PAGE on a Bio Rad electrophoresis system using the 
method of Laemmli
58
.  Samples were electrophoresed on 10 % acrylamide gels for 45 min at 200 
V in an electrophoresis tank with SDS running buffer (25 mM Tris, 192 mM glycine, 3.5 mM 
SDS).  Samples were prepared with 2X loading buffer (125 mM Tris-HCl pH 6.8, 20% glycerol, 
4% SDS, 3% DTT or 2 % 2-mercaptoethanol, 0.001% bromophenol blue) 
2.2.5 General strategy for purification of enzymes 
 Flavin adenine dinucleotide (FAD) from Sigma was added in at least 2-fold excess (200 
µM - 800 µM FAD) to recombinant flavoprotein-containing crude extracts before purifications, 
unless noted otherwise.  Enzymes were purified from crude extracts using a series of 
chromatographic columns.  The following columns were used, in order: DEAE Sepharose Fast 
Flow, Phenyl-Sepharose, Sephacryl S-300 gel filtration, and a second DEAE column if necessary 
(Table 2.6).  In between the DEAE and Phenyl-Sepharose steps there was an ammonium sulfate 
precipitation step.  During all purification steps, enzyme preparations were kept at 0-4 
o
C and in 
50 mM Tris-HCl pH 7.6 buffer, unless otherwise stated.   
2.2.6 Procedure for DEAE (anion exchange) column chromatography 
 The DEAE column (2.6 cm  x  25 cm) was equilibrated with 50 mM Tris-HCl pH 7.6 
buffer (or 100 mM Tris-HCl pH 7.6 in the case of A. niger 767).  Crude extract was loaded onto 
the column at a flowrate of 2 mL/min.  The column was washed with the same equilibration 
buffer at a flow rate of 2 mL/min. Proteins were eluted with a 0-500 mM NaCl gradient over 500 
mL of equilibration buffer at a flow rate of 2 mL/min.  Eluate was collected in 10 mL fractions.  
Proteins were located in fractions by measuring OD280 as well as OD450 for flavoproteins, and 
performing activity assays (see below), as well as analysis on 10 % SDS-polyacrylamide gels.  




2.2.7 Concentration of pooled fractions via ammonium sulfate precipitation 
 Ammonium sulfate was added to the pooled DEAE fractions up to 70 % saturation (or 60 
% in the case of A. niger 999 and A. niger 534), stirred for  30 min, and then the precipitated 
protein was collected by centrifugation  at 8 500 x g for 10 min.  Following removal of 
supernatant, protein precipitates were dissolved in 50 mM Tris-HCl pH 7.6 buffer, containing 20 
% ammonium sulfate, and centrifuged to remove any remaining particulate material.  The 
resulting supernatant then was ready to be loaded onto the Phenyl-Sepharose column. 
2.2.8 Procedure for Phenyl-Sepharose (hydrophobic interaction) column chromatography 
 The Phenyl-Sepharose column (2.6 cm x 14 cm) was pre-equilibrated with 50 mM Tris-
HCl pH 7.6 buffer containing 20 % ammonium sulfate, at a flow rate of 1 mL/min.  Samples 
from the ammonium sulfate precipitation step were loaded onto the column, which then was 
washed with buffer containing  20 % ammonium sulfate at a flow rate of 1 mL/min and eluted 
with a decreasing ammonium sulfate gradient (to 0 % ammonium sulfate) over 450 mL.  Proteins 
were located in fractions by measuring OD280, OD450 (for flavoproteins), and performing activity 
assays (see below), as well as analysis on 10 % SDS-polyacrylamide gels.  The purest fractions 
were combined and concentrated for the next step using a Millipore ultrafiltration membrane 
with a 30 000 Da cut-off. 
2.2.9 Procedure for Sephacryl S-300 (size exclusion) column chromatography 
 The Sephacryl S-300 column (2.6 cm x 78 cm) was equilibrated with 50 mM Tris-HCl, 
pH 7.6 buffer containing 100 mM NaCl.  The sample from the previous step was loaded at a 
flowrate of 1 mL/min, and proteins were eluted with the same buffer (also at a flowrate of 1 
mL/min).  Eluted fractions were collected and the enzyme was located as described for the 
previous steps.  The purest fractions were combined and concentrated and then stored at -20 
o
C 
(short term) or -80 
o
C (long term).  Some aliquots were stored in 10 % glycerol for increased 
stability. 
2.2.10 Second DEAE chromatography step 
 In some cases (Table 2.6), a second DEAE chromatography step was added after the 
Sephacryl S-300 step.  The DEAE column (1.6 cm  x  15 cm) was equilibrated with 50 mM Tris-
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HCl pH 7.6 buffer.  Crude extract was loaded onto the column at a flowrate of 1 mL/min.  The 
column was washed with the same equilibration buffer at a flow rate of 1 mL/min. Proteins were 
eluted with a 0-500 mM NaCl gradient over 300 mL of equilibration buffer at a flow rate of 2 
mL/min.  Eluate was collected in 5 mL fractions.  Proteins were located in fractions by 
measuring OD280, OD450 for flavoproteins, and performing activity assays (see below), as well as 
analysis on 10 % SDS-polyacrylamide gels. Fractions containing the purest protein of interest 
were combined and stored at -20 
o
C for short term storage and -80 
o











767 X X X   
577 X X X X X 
716 X X X X  
999 X X X X  
534 X X X   
Table 2.6: Purification steps used for each enzyme preparation.  The protein ID is based on the 
JGI ID number. 
2.2.11 TCA precipitation of enzymes in preparation for protein quantification 
 In preparation for quantification, proteins were precipitated with trichloroacetic acid
59
. 
For this, 50 μL samples were prepared, with appropriate dilutions.  Then, 1 mL of distilled H2O 
and 100 μL of 0.15% sodium deoxycholate was added to each sample and mixtures were 
incubated for 15 min at room temperature.  After incubation, 100 μL of trichloroacetic acid (72 
%) was added to each sample, followed by mixing,  and centrifugation at 13 000 rpm for 15 min 
at room temperature.  Supernatants were removed and 50 μL of 5 % SDS in 0.1 M NaOH was 





2.2.12 Estimating protein concentrations 
 Samples (50 μL) and standards of appropriate dilutions were prepared in 1.5 mL 
microtubes.  Standards (bovine serum albumin, BSA) were prepared according to the instructions 
provided for the Pierce BCA Protein Assay Kit.  Samples and standards were treated via TCA 
precipitation as described above to remove any interfering compounds.    Then, 1 mL of BCA 
working reagent (50 parts Pierce BCA Reagent A + 1 part of Pierce BCA Reagent B) was added 
to each tube and the contents were mixed.  Reaction mixtures were incubated at room 
temperature for 2 h, and then their absorbances were measured at 562 nm.   A standard curve was 
prepared by plotting the corrected A562 values vs. BSA standard concentrations.  Concentrations 
of unknowns were then determined using the standard curve and applying any dilution factors 
necessary. 
2.3 Enzyme Characterization Experiments 
2.3.1 Identifying bound flavins 
 Protein bound flavin samples were prepared by boiling A. niger 767, 577, 534, and 999 to 
release any non-covalently bound flavin and centrifuging out the protein precipitate.  These 
flavin sample supernatants for the 4 enzymes were spotted (10-20 times) on a Whatman silica-
coated fluorescent TLC plate together with genuine FAD and FMN samples.  The chromatogram 
was developed using a solvent of n-butanol: acetic acid: H20 (4:1:5)
60
.  Since FAD and FMN can 
be detected by their yellow color, no visualization procedure was required.  However spots could 
also be visualized under UV light (254 nm). 
2.3.2 Estimating number of FAD binding sites in purified proteins 
 The number of FAD binding sites was determined using the following equation: 
# of FAD Active Sites = 
𝑚𝑜𝑙  𝑜𝑓  𝐹𝐴𝐷
𝑚𝑜𝑙  𝑜𝑓  𝑃𝑟𝑜𝑡𝑒𝑖𝑛
 
The concentration of enzyme was determined using the BCA protein assay described above.  The 
concentration of  FAD was estimated by first releasing FAD from the protein via denaturation at 
100 
o
C for 5 min, then centrifuging the sample to remove precipitated protein, and finally 
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measuring the OD450 of the resulting supernatant.  The concentration of FAD was then calculated 







2.3.3 Preparation of substrates 
 All substrates were the purest available commercially and prepared in autoclaved distilled 
water or milli-Q, water to a concentration of 10 mM.  If substrate was not fully soluble in water, 
a few microliters of 1 M NaOH was added until the substrate dissolved. NADH or NADPH were 
prepared in 2 mM Tris base and the concentration of NAD(P)H was verified by measuring the 







2.3.4 Enzymatic assays for hydroxylases and decarboxylases 
 Enzymatic activities of hydroxylases were  monitored at 340 nm to follow NAD(P)H 
consumption.  An  assay mixture (1 mL) consisted of 200 μM NAD(P)H, and 200 μM aromatic 
substrate, in 50 mM Tris-HCl pH 7.6 buffer at 25
o
C.  The amount of enzymes added to the assay 
mixtures were as follows for each A. niger preparation: 6.59 μg 767, 7.37 μg  577, 34.9 μg 534, 
or 15.0 μg 999).    All reaction components except enzyme were mixed initially, and absorbance 
was monitored for a few seconds until a stable baseline was established: then enzyme was added 
and absorbance changes were recorded.  Control assays without substrate were carried out to be 
able to subtract the consumption of NAD(P)H in the absence of aromatic substrate.   
 The enzymatic assay for the A. niger 2,3-dihydroxybenzote decarboxylase (A. niger 716) 
was carried out by measuring the rate of 2,3-dihydroxybenzoic acid consumption at 305 nm
38
.  
The assay (1 mL) contained 300 μM 2,3-dihydroxybenzoic acid (2,3-DHBA) and 16.27 μg of 
enzyme in 20 mM Bis-Tris pH 6.2 buffer at 25 
o
C.  The buffer and substrate were combined and 
the absorbance of the mixture was monitored for a few seconds to ensure a stable baseline was 
achieved, then enzyme was added and the reaction was followed at 305 nm where the extinction 





 The reverse reaction of the decarboxylase was monitored by measuring the rate of  2,3-
DHBA production at 305 nm when catechol was used as a substrate
38
.  The assay (1 mL) 
consisted of 300 μM catechol, 0.25-1.00 M KHCO3 (potassium bicarbonate) in 100 mM 
phosphate buffer pH 6.2 at 25 
o
C.  The absorbance of the assay mixture was then measured for a 
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few seconds in order to ensure a stable baseline was achieved, and then finally 81.4 μg of  A. 
niger 716 was added and the reaction was monitored at 305 nm until completion. 
2.3.5 Assay for catechol production 
 Catechol production was observed by coupling reactions to catechol 2,3-dioxygenase
61,62
.  
In this assay, absorbance was measured at 400 nm to monitor 2-hydroxymuconate-6-
semialdehyde formation.  Assays were carried out in 50 mM Tris-HCl pH 7.6 buffer (1 mL) 
containing 200 μM NAD(P)H, monooxygenase enzyme (for each A. niger enzyme preparation 
16.5 μg 767, 18.4 μg 577, 34.9 μg 534, or 15.0 μg 999) and Pseudomonas CF600 catechol 2,3-
dioxygenase (2 Units) at 25 
o
C.  After a baseline absorbance was established, salicylate or phenol 
(200 μM) was added,  and activity was measured from the change in absorbance at 400 nm. 
 In addition, catechol 2,3-dioxygenase was observed to be active on 4-methylcatechol, 3-
methylcatechol, and hydroxyquinol, so the enzyme assay described above was used when there 
was a possibility of any of these compounds being produced, with any of the four hydroxylase 
enzymes investigated.  
2.3.6 Sample preparation for product analysis by TLC 
 Standards of substrates and expected products were prepared in ethyl acetate at a 10 mM 
concentration.  Reaction mixtures to generate products contained 200 μM aromatic substrate, 600 
μM NAD(P)H, enzyme (13.2 μg 767 or 14.7 μg 577) in 50 mM Tris-HCl pH 7.6 buffer (1 mL), 
and were run for at least 10 min at 25 
o
C.  A few drops of 6 M HCl were then added to the 
reaction mixtures to protonate any products and precipitate enzyme.  Reaction mixtures were 
then centrifuged in a microfuge at maximum speed for 5 min, and the supernatant was removed 
and decanted into glass test tubes.  Supernatants were extracted two times with 2 mL of ethyl 
acetate.  Combined ethyl acetate extracts were then taken to dryness by evaporation under 
nitrogen gas, and residues were dissolved in 100 μL of ethyl acetate prior to TLC analysis.  
2.3.7 TLC product analysis 
 Mobile phase consisting of chloroform: ethyl acetate: acetic acid (50:50:1)
63
 was poured 
into a TLC chamber lined with a pierce of filter paper .  TLC plates used were Whatman silica 
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coated TLC plates with fluorescent indicator.  Samples were spotted (10-20 times) 1 cm from the 
bottom of the TLC plate using finely-drawn capillary tubes.  TLC plates then were placed into 
the chamber and run until the solvent front reached a few millimeters from the top.  The plate 
was then visualized under UV light (254 nm) and spots were marked using a pencil.  Rf values 
(or retention factors)  were calculated for each spot using the formula
64
: 
𝑅𝑓 =  
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑓𝑟𝑜𝑚 𝑜𝑟𝑖𝑔𝑖𝑛
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑜𝑓 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 𝑓𝑟𝑜𝑛𝑡 𝑓𝑟𝑜𝑚 𝑜𝑟𝑖𝑔𝑖𝑛
 
2.3.8 Oxygen monitoring experiments 
 Reaction mixtures (1 mL) contained 50 mM Tris-HCl pH 7.6 buffer with 200 μM 
NADH, 300 μM aromatic substrate, and enzyme (for each A. niger protein 65.9 μg 767, 36.9 μg 
577, 69.8 μg 534, or 150 μg 999).  Reaction conditions were modified from  the conditions used 
by White-Stevens et al
29
.  Oxygen concentrations in these assays were measured using a 
Hansatech oxygen electrode (K140) Oxygraph + oxygen monitoring system.
65
  The buffer was 
initially added to the chamber, and the oxygen concentration was monitored as NADH and 
aromatic substrate were added sequentially using a syringe.  Hydroxylase enzyme was then 
added, and the decrease in oxygen concentration was observed.  Once the oxygen concentration 
reached a plateau, 200 Units of catalase (Sigma-Aldrich) was added and the reaction was 
followed until oxygen production ceased.  Calibration of the instrument was achieved by 
following the calibration procedure outlined in the instrument manual using air-saturated water 
and water with excess sodium dithionite (to completely consume O2) added.  All reactions and 
calibration were performed at 25 
o
C at ambient pressure.  Atmospheric pressure was obtained 
from a weather website: (http://www.theweathernetwork.com/ca/weather/quebec/montreal), and 
was always around 101.3 kPa.  
2.3.9 Substrate binding via monitoring FAD fluorescence, determining Kd 
 Determination of the Kd values for binding of aromatic substrate to A. niger hydroxylases 
were determined by measuring changes in FAD fluorescence emission at 525 nm, with an 
excitation wavelength of 450 nm, upon the addition of substrate.  Successive substrate additions 
were made into 1 mL 50 mM Tris-HCl pH 7.6 buffer containing enzyme (5 μM) at ambient 
temperature.   All measurements were conducted using a Varian Cary Eclipse fluorescence 
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spectrometer.  Recorded fluorescence spectra were an average of 10 scans recorded at 600 
nm/min with slit sizes of 5 nm and 10 nm for excitation and emission slit sizes respectively.    
The results were then plotted as ΔFI/ΔFImax versus the concentration of substrate, where ΔFI is 
defined as the change in fluorescence from the initial fluorescence and ΔFImax is defined as the 
largest fluorescence change (at the highest substrate concentration).  Florescence data were 
corrected for dilution by multiplying measured fluorescence emission by final volume/initial 
starting volume.   Kd was then determined using the OriginLab software and fitting the data to 
the Hill1 equation (shown below):  




where "start" is the x value  at the lowest substrate concentration and "end" is the x value of the 




2.3.10 Molecular weight and oligomeric state determination of proteins using gel filtration 
 Gel filtration experiments were performed using the Superdex 200 10/300 GL column 
connected to a BioRad BioLogic DuoFlow HPLC.  The column was equilibrated with 50 mM 
Tris-HCl, 100 mM NaCl pH 7.6 buffer, and eluted at a flow rate of 0.65 mL/min.  All protein 
elution volumes were determined using a UV detector that measured OD280 as samples eluted 
from the column.  The void volume was determined by measuring the elution volume of blue 
dextran (500 μL, 2 mg/mL).  Elution volumes were also determined for Bio-Rad gel filtration 
standards (500 μL), consisting of thyroglobulin, γ-globulin, ovalbumin, myoglobin, and vitamin 
B12.
66
  A standard curve of Kav vs log(Mw) was then plotted using elution volumes of the 






, where Ve= elution volume, Vt= elution volume of smallest standard, V0= void 
volume. 
Purified A. niger proteins (0.5-1 mg, 500 μL) were then loaded onto the column and their elution 
volumes were measured.  The Kav values of these unknowns were calculated, and their molecular 
weights were estimated based on the standard curve.  In addition the oligomeric state of the 
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enzyme was determined by dividing the observed molecular weight by the expected mass of a 
single monomer based on the amino acid sequence. 
2.3.11 pH-activity profile of 2,3-dihydroxybenzoate decarboxylase 
 The standard assay described above was used with buffers of varying pH.  All buffers 
consisted of 20 mM Bis-Tris and were pH adjusted with HCl to pH values within a range of 5.8-
7.2. 
2.3.12 Metal chelation of A. niger 2,3-Dihydroxybenzoate decarboxylase  
 A protein sample (0.9 mL of 0.2 mM A. niger 2,3-dihydroxybenzoate decarboxylase) was 
inserted into a ThermoFisher Scientific Slide-A-Lyzer dialysis cassette (3 mL limit, 20 kDa cut-
off), and dialyzed against 500 mL chelation buffer (50 mM Tris-HCl, 50 mM imidazole, 50 mM 
8-hydroxyquinoline-5-sulfonic acid and 50 mM EDTA pH 7.4) at 4 
o
C with constant stirring.  
Dialysis was continued for 2 h followed by transfer to fresh dialysis buffer, and additional 
dialysis overnight.  The following day the cassette was transferred to 500 mL 50 mM Tris-HCl 
buffer pH 7.6 (to remove chelator) and dialyzed for 2 h.  The dialysis buffer was changed one 
final time, and dialysis was continued overnight to remove any remaining chelator (procedure 
adapted from Atkin et al, 1973
67
).  Additionally, 50 mM Tris-HCl buffer pH 7.6 (control) also 
underwent dialysis simultaneously using the same methodology.    The sample was removed 
from the dialysis cassette using a syringe and stored at -20 
o
C.  Loading and removal of the 




2.3.13 Metal detection of enzymes via ICP-MS  
 All materials used in preparation of samples for ICP-MS were soaked in 10 % low trace 
metal nitric acid and rinsed with Milli-Q water.  50 mM Tris-HCl pH 7.6 and nitric acid 
solutions were prepared in Milli-Q water as well.   For ICP-MS analysis samples containing 0.1 
mg of protein were prepared: samples were then digested in 10 % HNO3 at 50
o
C for 2 days
69
.  
Digested samples were centrifuged in a microcentrifuge at max speed for a few minutes to 
remove all of the digested protein.  Supernatants were transferred to a nitric acid treated 
centrifuge tube and brought to the Centre for Biological Applications of  Mass Spectrometry. 
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Buffer controls were prepared in the same manner. The samples were run by Alain Tessier on the 
LC-ICP-MS (Agilent 7500ce).  Additionally, standards of known metal concentrations were 
prepared and measured to be able to prepare a standard curve which would then be used to 
measure metal content of the unknowns.  Metals investigated were Mg, Ca, Mn, Fe, Co, Cu, and 
Zn.  
2.4 Bioinformatic and Computational Studies  
2.4.1 Construction of homology models 
 Protein models were generated using the I-TASSER Protein Structure and Function 
prediction server (default parameters) by submitting the primary amino acid sequence.
70
  I-
TASSER models provide only the coordinates of the apo-enzyme.  For a model with bound co-
factor and/or substrate, these molecules were added manually.  This was performed by finding a 
similar homologue with the molecule of interest, aligning the model to the homologue in 
PyMOL and then copying the new coordinates of the co-factor or substrate from the aligned 
template to the model being constructed.
71
 
2.4.2 Sequence alignments and construction of phylogenetic trees 
 Sequence alignments and phylogenetic tree construction was performed by submitting 
query sequences to the Clustal Omega server
72,73
.  In all cases, protein sequences of interest were 
aligned to determine similarity in specific regions.  In many cases, other characterized enzymes 
(retrieved from UniProt) of the same class were included in the alignment.  In addition the 
sequences of enzymes of interest were included in phylogenetic trees to help visualize the 
similarity between specific enzymes, and help to rationalize possible enzyme characteristics, 








3.1  Selection of A .niger Aromatic Ring Hydroxylase Genes 
 The  Aspergillus niger genome contains many genes annotated as aromatic ring 
hydroxylases.   Upon searching the two publically-available A. niger genomes (ATCC 
1015v4.0
22
 and the NRRL3
23
) using text searches such as "monooxygenase", "hydroxylase", or 
"aromatic-ring hydroxylase" more than 60 hits were found (data not shown).  Further inspection 
of these hits showed that some have very low sequence identity with known aromatic 
hydroxylase enzymes.  Most of these hits to "known" aromatic hydroxylases were for salicylate 
hydroxylase or phenol hydroxylase.  For the salicylate hydroxylases, genes encoding the top five 
A. niger sequences most similar to P. putida (bacterial) salicylate hydroxylase (Uniprot ID: 
Q23262
11
) and a less similar enzyme were selected.  In the case of the phenol hydroxylase 
annotated sequences, genes encoding proteins most similar to Trichosporon cutaneum phenol 
hydroxylase (Uniprot ID: P15245
74
) were initially chosen, although as will be shown later, most 
of these were not successfully amplified by PCR.  Additional genes annotated as phenol 
hydroxylase were thus chosen based on the relatively high expression levels observed in the 
cDNA that was used as template (unpublished data). 
 The list in Table 3.1 represents all 14 predicted hydroxylases  chosen for the 
experimental work in this thesis, and summarizes the best Blast hit from the Uniprot/Swissprot 
databases for each of the predicted sequences.  Interestingly, the Blast results indicate that very 
few of the A. niger hydroxylase sequences showed identity above 35 % to their bacterial 
counterparts, with the highest identity only being 38 %.    
 Blast searches also reveal superfamily domains, summarized in Table 3.2.  All the protein 
targets contain a NADB_Rossmann superfamily domain which identifies the Rossmann fold, the 
site of dinucleotide cofactor binding which is observed in flavoproteins utilizing 
NAD(P)H/NAD(P)
75
.   The protein sequences annotated as phenol hydroxylase have an 




 For the remainder of this thesis protein ID's will be abbreviated to the last 3 digits of the 

































































































































89 4E-75 38 
*Blast results calculated using protein sequences available on the Uniprot/Swissprot database in 
September 2014 




JGI Protein ID Superfamily/Domains 
1127577 NADB_Rossmann superfamily   
1205534 NADB_Rossmann superfamily   
1223684 NADB_Rossmann superfamily   
1114655 NADB_Rossmann superfamily   
1183860 NADB_Rossmann superfamily   
1206422 NADB_Rossmann superfamily Thioredoxin_like superfamily 
1210999 NADB_Rossmann superfamily Thioredoxin_like superfamily 
52617 NADB_Rossmann superfamily Thioredoxin_like superfamily 
1125300 NADB_Rossmann superfamily Thioredoxin_like superfamily 
1125146 NADB_Rossmann superfamily Thioredoxin_like superfamily 
1159718 NADB_Rossmann superfamily Thioredoxin_like superfamily 
1227951 NADB_Rossmann superfamily Thioredoxin_like superfamily 
1085687 NADB_Rossmann superfamily Thioredoxin_like superfamily 
1185767 NADB_Rossmann superfamily   
Table 3.2: Predicted superfamily domains of target proteins 
3.2 Salicylate Hydroxylases 
3.2.1 PCR amplification to purification 
 Predicted salicylate hydroxylase gene sizes are listed in Table 3.3 below, together with 
protein molecular weight estimated using the Protparam
77
 tool which predicts protein 
characteristics by inputting the amino acid sequence. 
A. niger JGI 
ID 
Expected gene size 
(base pairs) 
Expected protein molecular weight 
(kDa) 
1127577 1311 48.4 
1185767 1314 47.9 
1205534 1317 48.2 
1223684 1365 47.2 
1114655 1332 48.4 
1183860 1275 47.0 
Table 3.3: Expected DNA and protein sizes of putative salicylate hydroxylases 
 Obtaining protein to characterize enzymes requires successful PCR amplification from 
template DNA, cloning, transformation, expression, and purification.  Any one of these steps can 
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fail, for various reasons.  Shown in Table 3.4 is the success of each step for the putative 
salicylate hydroxylase sequences of interest.  The symbol () in each cell indicates that the step 
was successful, while the symbol () cell indicates that the specific step was not successful. 
  Steps Achieved  
A. niger 
JGI ID 
PCR Amplification Cloning Expression Purification Characterization 
1127577      
1185767      
1205534      
1223684     
 
1114655     
 
1183860    
  
Table 3.4: Summary of steps achieved with A. niger putative salicylate hydroxylase  
 Three enzymes, A. niger 767, 577, and 534, were all successfully expressed and 
characterized.  A. niger 684 was successfully expressed but not characterized any further since 
no hydroxylase activity was observed.  A. niger 655 was successfully expressed but did not 
express in the soluble fraction in any of the conditions tested.   Finally,  A. niger 860 did not 
express in either the soluble or insoluble fractions in any of the conditions attempted.  These 
results will be presented in detail below. 
 3.2.1.1 PCR amplification of Aspergillus niger genes annotated as salicylate 
hydroxylases 
 Putative salicylate hydroxylase genes listed in Table 3.3 were subjected to amplification 
by PCR using cDNA derived from A. niger grown on 2% alfalfa and barley, as described in 
Materials and Methods. Amplified fragments all appeared to be the expected sizes (Fig. 3.1).  
The resulting DNA fragments were cloned into the pLATE 11 vector and the presence of 
inserted DNA fragments was screened via restriction digestion and/or PCR amplification (See 
examples below in Fig. 3.2 and Fig 3.3).   To verify that the correct DNA insert was cloned into 
the pLATE11 plasmid, the recombinant plasmids were sequenced at the McGill University 
Genome Quebec Innovation Centre.  All putative salicylate hydroxylase  sequences in Table 3.3 




Figure 3.1: PCR Amplification of A. niger 767 (A), 577 (B), 534 (C), 860 (D), 655 (E), and 684 
(F) run on 0.8% Agarose Gels.  Numbers pointing to bands represent base pair sizes, where  
numbers pointing to PCR fragments represent theoretical base pair sizes.   
3.2.1.2  Plasmid screening for correct inserts 
 Shown in Fig 3.2 is an example of a restriction digest where a plasmid construct has two 
NdeI cut sites, one located in the core pLATE11 plasmid and the other in the gene insert, thus, 
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cleavage of a plasmid with the correct insert should result in two bands.  The expected correctly 
sized bands appear to be present at around 2201 bp and 3565 bp, indicating the insert is the 
expected size, and in the correct orientation.  
 
Figure 3.2: Example of plasmid screening using restriction digestion (A).  Blue regions represent 
gene insert while black portion represents pLATE11.  Cut sites are indicated in black by the NdeI 
label.  NdeI restriction enzyme digest of A. niger 767 plasmid construct run on a 0.8% agarose 
gel (B). Similar tests were done with other plasmid constructs (data not shown).   
 A second method to screen plasmid DNA from single colonies of transformed cells 
involved using purified plasmids as PCR templates and amplifying inserts using the LIC 
sequencing primers.  The sizes of the inserted fragments were then estimated on agarose gels, 
with some examples shown in Fig 3.3.  Fragments amplified using this method were 178 bp 
larger than the size of the cloned gene since the LIC primers bind short distances upstream and 




 Figure 3.3: Screening plasmid inserts for constructs of A. niger 767 (A), 577 (B), and 534 
(C).  DNA fragments generated via PCR using plasmid as a template and amplifying insert 
fragment. 
 In Fig 3.3 the fragments visualized appear to be of the expected size taking into account 
these considerations (expected sizes of 1492 bp, 1489 bp and 1495 bp for A. niger 767, 577, and 
534 respectively).  As this method is used to screen for the correct insert, plasmids from all 
colonies do not always contain the correct insert.  Thus, in Fig 3.3A  only one colony (lane 6) 
contained a correctly-sized insert, while in Fig 3.3B plasmids from all colonies contained a 
correctly-sized insert. 
 Finally, the plasmids confirmed by the methods described above were then subjected to 
DNA sequencing to insure that only proteins with the correct intended sequence would be 
produced in subsequent steps. 
3.2.1.3 Heterologous expression of salicylate hydroxylases in E. coli 
 Once the plasmid sequences were verified, protein expression was attempted by 
transforming the plasmid into E. coli BL21 (DE3), growing the cells, inducting expression by the 
addition of IPTG, extracting the proteins, and running the samples on SDS polyacrylamide gels 
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with the appropriate controls.  Both the soluble and pellet fractions were analyzed, in case the 
protein expressed in inclusion bodies.  Induced samples were usually compared with samples 
from cells prior to addition of IPTG to see that the protein band was not simply a host protein.  
Different expression conditions and hosts were attempted when initial attempts to produce 
soluble protein proved to be unsuccessful.   
 As summarized in Figure 3.4, expression was successful for 5 of the 6 selected putative 
salicylate hydroxylases: SDS-polyacrylamide gel results are shown in Fig. 3.4.  This figure is 






Figure 3.4: Soluble and insoluble fractions from BL21 (DE3) cells harbouring expression 
plasmids for A. niger 767 (A), 534 (B), 577 (C), 655 (D), and 684 (E) grown under various 
conditions.  Samples were run on 10 % SDS-polyacrylamide gels.  Lanes labelled Mw, E, S, and 
P represent molecular weight markers, empty lane, supernatant (soluble cell fraction), and pellet 
(insoluble cell fraction) respectively.   Lanes with a negative sign (-) indicate samples from 
uninduced cells while a positive sign (+) indicates, that the cells have been induced.  Lanes 
containing protein from induced cells have the induction temperature designated at the bottom of 
the lane.  Finally, expressed target protein bands are indicated by an arrow pointing to them, with 
their estimated molecular weights listed alongside. 
 A. niger 767, 534, and 577 were all well expressed in soluble form (Fig. 3.4A-C).  The A. 
niger 767 and 577 proteins were only expressed in soluble form when induction was done at 16 
o
C, thus all further expression trials were done at 16
o
C.    On the other hand, A. niger 655 protein 
was only expressed in insoluble form, even at 16 
o
C (Fig. 3.4D), and was not pursued further.  
The A. niger 684 target appeared to be produced in soluble form in small amounts (Fig. 3.4E), 
but crude extracts containing the protein showed no detectable activity on salicylate or any of the 
other related compounds tested using the NADH consumption assay described in  Materials and 
Methods.  The target A. niger 860 also did not show any expression under the conditions used for 
the above sequences (data not shown).  Testing expression of these two targets in E. coli Shuffle 
Express 
78
 or Rosetta (DE3)
57
 did not result in any expressed target protein even though the 
plasmid construct was deemed to be correct via DNA sequencing (data not shown).  So these two 









3.2.1.4 Purification of three putative A. niger salicylate hydroxylases 
 The three successfully expressed and soluble putative salicylate hydroxylases, A. niger 
767, 577, and 534, were each purified using combinations of column chromatography steps as 
outlined in Materials and Methods. 
 A. niger 767 (47.9 kDa) was purified to near homogeneity via a 3-step purification 
procedure consisting of the following steps: DEAE (ion-exchange chromatography),  ammonium 
sulfate precipitation, and phenyl-Sepharose (hydrophobic interaction chromatography).  The 
purity after each step was visualized after running samples on a 10 % SDS-polyacrylamide 
electrophoresis gel (Fig. 3.5).  A summary of the overall purification is presented in Table 3.5. 
After the final step it is clear that nearly all contaminating E. coli proteins were removed (Fig 
3.5, lane 6), and purification resulted in a specific activity increase of nearly 4 fold (Table 3.5).  
 
Figure 3.5: Purification of A. niger 767 as monitored after electrophoresis on a 10 % SDS-
polyacrylamide gel. Protein low molecular weight standards (lane 1); crude extract (lane 2);  
pooled DEAE fractions (lane 3); ammonium sulfate concentrated DEAE fractions (lane 4). 


























Crude Extract 26.0 16.9 23.9 439 621 1.41 - 100 




13.0 7.50 22.5 97.5 292 3.00 2.12 47.1 
Phenyl- 
Sepharose Pool 
45.0 0.84 4.13 37.8 186 4.91 3.47 29.9 
Pure enzyme 4.50 6.59 33.8 29.7 152 5.13 3.63 24.5 
*One unit (U) is defined as the amount of enzyme required to oxidize one μmol/min of NADH 
using salicylate as a substrate in 50 mM Tris-HCl pH 7.6 at 25 
o
C. 
Table 3.5: Purification summary for A. niger 767  
 A. niger 577 (48.4 kDa) was purified in a similar fashion to A. niger 767.  It was a 4-step 
purification in which the crude extract was chromatographically separated on a DEAE column, 
and continued with chromatography on a phenyl-Sepharose column, Sephacryl S-300 column 
(gel filtration), and finally a second DEAE column.  Before being loaded on the phenyl-
Sepharose column the protein was concentrated by ammonium sulfate precipitation (not shown).  
The purity of the protein preparation was monitored after each step (Fig. 3.6): Table 3.6 
summarizes the purification.  Note that activity and protein assays were not performed for the 
phenyl-Sepharose combined fractions because no aliquot of the pooled fractions was kept for 
analysis.  The specific activity of the enzyme increased nearly 4 fold after the purification, and a 
nearly homogenous final preparation was achieved, although some minor contaminants are still 
visible (Fig. 3.6, lane 7).  The second DEAE step does not significantly change the specific 
activity or improve the purity of the final preparation, and lowered the yield (although 25 % of 




Figure 3.6: Purification of A. niger 577 as monitored after electrophoresis on a 10 % SDS-
polyacrylamide gel.  Protein low molecular weight markers (lane 1); empty well (lane 2); crude 
extract (lane 3); pooled DEAE fractions (lane 4); pooled phenyl-Sepharose fractions (lane 5); 






















Crude Extract 60.0 12.5 85.5 751 5.13E+3 6.83 - 100 
DEAE 112 1.94 43.3 217 4.85E+3 22.3 3.27 94.5 
phenyl 
Sepharose 
282 NA NA NA NA NA NA NA 
S-300 
(concentrated) 
5.00 7.37 188 36.9 941 25.5 3.74 18.3 
DEAE 2 
(concentrated) 
2.50 4.77 121 11.9 302 25.3 3.70 5.88 
*One unit (U) is defined as the amount of enzyme required to oxidize one μmol/min of NADH 
using salicylate as a substrate in 50 mM Tris-HCl pH 7.6 at 25 
o
C. 
Table 3.6: Purification summary for A. niger 577 
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 A. niger 534 (48.2 kDa)  was successfully purified via a 3-step purification procedure 
consisting of a DEAE column, ammonium sulfate precipitation, and finally a phenyl-Sepharose 
column.  Fig. 3.7 and Table 3.7 summarizes the purification procedure and show that after 
purification the protein approaches near homogeneity resulting in approximately 3-fold increase 
in specific activity. 
 
Figure 3.7: Purification of A. niger 534 as monitored on a 10 % SDS-polyacrylamide gel. Protein 
low molecular weight markers (lane 1); crude extract (lane 3);  pooled DEAE fractions (lane 5);  
ammonium sulfate concentrated DEAE fractions (lane 7); pooled phenyl-Sepharose fractions 























Crude 32.0 21.1 3.01 676 96.3 0.143 1.00 100 
DEAE + ASP 7.50 15.2 6.55 114 49.1 0.430 3.02 51.0 
phenyl-
Sepharose 
4.00 14.0 6.06 55.8 24.2 0.434 3.05 25.2 
*One unit (U) is defined as the amount of enzyme required to oxidize one μmol/min of NADH 
using salicylate as a substrate in 50 mM Tris-HCl pH 7.6 at 25
o
C. 




3.2.2: Salicylate Hydroxylases: Characterization 
3.2.2.1 UV-visible absorbance characteristics and identification of the accompanying flavin 
 All known salicylate hydroxylases are flavoproteins which contain FAD (flavin adenine 
dinucleotide).  FAD is a molecule that includes a chromophore with distinctive peaks at 375 nm 
and 450 nm, giving flavoproteins their distinct yellow color.  UV-visible absorbance spectra 
characteristic of flavoproteins were observed for all 3 of the purified proteins (Fig 3.8).  The 
peak at 280 nm is predominantly due to the protein's aromatic amino acids, but also flavin, while 
the other two peaks at 375 nm and 450 nm are due to bound flavin.  The flavin peaks were 




Figure 3.8: UV-VIS spectra of purified putative salicylate hydroxylases and released flavin for A. 
niger 767 (A), 577 (B), and 534 (C) in 50 mM Tris-HCl pH 7.6 at 25 
o
C.  Each graph shows a 
full spectrum, and a focused flavin spectrum.  Released flavin is the flavin absorbance of the 
supernatant after thermal denaturation and removal of the protein. 
 
Figure 3.9:  Identification of putative A. niger  salicylate hydroxylase flavins by TLC.  FMN 
(lane 1); FAD (lane 2); A. niger 767 flavin (lane 3); A. niger 577 flavin (lane 4); and A. niger 534 
flavin (lane 5).  Samples were  developed on a Whatman silica-coated TLC plate using a 
developing solvent of n-butanol: acetic acid: H20 (4:1:5)
60
 and visualized under UV light. 
3.2.2.2 Number of FAD binding sites 
 The next step was to determine the stoichiometry of FAD binding for each protein using 
the data shown in the previous section.  The concentration of FAD was determined by using the 




 at 450 nm after first releasing the FAD 
molecules from the protein by heating in a boiling water bath.  Once the FAD concentration was 
determined it was compared to that of the protein.  In all cases, there appeared to be one mole of 
FAD per mole of protein, indicating that all three of these putative salicylate hydroxylase binds a 
single FAD (Table 3.8).  
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Table 3.8 FAD to protein ratio of putative salicylate hydroxylases 
3.2.2.3 Oligomeric states of A. niger 767, 577, and 534 proteins 
 The oligomeric states of the purified proteins were determined by estimating the 
molecular weight of the proteins using gel filtration chromatography on a Superdex 200 10/300 
GL column, and comparing to the predicted subunit molecular weights.  The column was first 
calibrated by running protein standards (Bio-Rad) consisting of thyroglobulin, γ-globulin, 
ovalbumin, myoglobin, and vitamin B12.   Elution times of each standard were measured and the 
Kav values calculated as described in Materials and Methods and plotted against the Log Mw.  
The Kav of the purified proteins were determined in the same manner as the standards and the 
standard curve was used to estimate the corresponding molecular weights.   It was estimated that 
A. niger 767, 577, and 534 had molecular weights of 36.5 kDa, 80.1 kDa, and 77.7 kDa 
corresponding to a monomer, dimer, and dimer respectively (Table 3.9).   Elution profiles of all 









767 47.9 36.5 Monomer 
577 48.4 80.1 Dimer 
534 48.2 77.7 Dimer 
Table 3.9:  Estimated molecular weights & oligomeric states for putative A. niger salicylate 
hydroxylases. 
3.2.2.4 NADH/NADPH specificity 
 All 3 of the purified enzymes preferred utilizing NADH compared to NADPH (Table 
3.10), consistent with what is commonly reported for known bacterial salicylate hydroxylases.  
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Between the 3 enzymes, A. niger 767 seems to have a much higher preference for NADH to 
NADPH since only 13 % of the rate of consumption of NADH was achieved with NADPH 
compared to A. niger 577 and 534, where the relative values were 68.1 % and 49.2 % 
respectively.  
A. niger JGI 
ID 
Rate of NADH 
consumption 
(μmol/min/mg) 





relative to NADH 
(%) 
767 4.40 0.579 13.2 
577 25.4 17.3 68.1 
534 0.382 0.188 49.2 
Table 3.10: NADH/NADPH specificity of purified salicylate hydroxylases tested using salicylate 
as a substrate by monitoring the rate of NADH/NADPH consumption at 340 nm.  For all 
measured values NAD(P)H background consumption was subtracted, and all rate measurements 
were performed in duplicates with the average values represented.  The following amounts of 
protein was used for each of the A. niger enzymes: 6.59 μg 767, 7.37 μg  577, and 34.9 μg 534.   
3.2.2.5 Aromatic substrate specificities of putative salicylate hydroxylases 
 Once it was determined that the enzymes were more active with NADH as a co-substrate 
compared to NADPH,  NADH was used to measure the enzyme activities on various aromatic 
substrates (Table 3.11).  A. niger 767 was most active on 6-methylsalicylate with significant 
activity on 4-methoxysalicylate, salicylate, 4-methylsalicylate, and 5-methylsalicylate.  A. niger 
577 was most active on salicylate, 4-methylsalicylate, and 5-methylsalicylate while A. niger 534 
was most active on salicylate.  Comparison of the 3 purified hydroxylase enzymes reveals that 
their activities differ greatly on their most active substrates.  A. niger 577 is the most active of 
the three enzymes (39.1 μmol/min/mg on 4-methylsalicylate), while 767 (13.91 μmol/min/mg on 
6-methylsalicylate) has significantly lower activity, and 534 (0.40 μmol/min/mg on salicylate) 






Rate of NADH 
Consumption 
(μmol/min/mg) 
*Relative Activity (%) 
 Substrate 
 
Enzyme  Enzyme  
767 577 534 767 577 534 
Benzoate 0.08 0.757 NA 1.0 2.4 NA 
Salicylate 7.68 31.69 0.40 100.0 100.0 100.0 
3-Hydroxybenzoate 0.02 0.02 0.00 0.3 0.1 -0.7 
4-Hydroxybenzoate 0.02 0.03 0.05 0.3 0.1 12.4 
2,3-Dihydroxybenzoic Acid 1.48 19.74 0.18 19.3 62.3 45.3 
2,4-Dihydroxybenzoic acid 4.29 18.16 0.40 55.9 57.3 99.9 
**2,5-Dihydroxybenzoic acid 0.42 44.16 0.13 5.5 139.3 32.3 
2,6-Dihydroxybenzoic acid 0.69 15.14 0.37 9.0 47.8 92.6 
3,4-Dihydroxybenzoic acid 0.00 0.02 0.09 0.0 0.1 22.8 
3-Chlorosalicylic acid 0.41 3.15 0.06 5.4 10.0 15.7 
4-Chlorosalicylic acid 0.42 10.91 0.34 5.5 34.4 85.2 
5-Chlorosalicylic acid 0.26 3.89 0.37 3.4 12.3 91.6 
3-Methylsalicylic acid 1.48 6.80 0.10 19.3 21.4 24.0 
4-Methylsalicylic acid 7.23 39.08 0.40 94.1 123.3 99.1 
5-Methylsalicylic acid 8.06 34.41 0.26 104.9 108.6 64.5 
6-Methylsalicylic acid 13.91 5.95 NA 181.2 18.8 NA 
4-Methyoxysalicylic acid 11.37 21.82 0.24 148.1 68.8 61.2 
Anthranilic Acid 0.38 0.51 0.02 4.9 1.6 3.8 
3-Hydroxyanthalic acid 0.45 NA NA 5.8 NA NA 
2-Hydroxyphenylacetic acid 0.08 0.07 - 1.1 0.2 - 
O-anisic acid 0.26 0.27 - 3.4 0.9 - 
6-hydroxypyridine 3-
carboxylic acid 
0.21 0.03 0.03 2.7 0.1 7.6 
Phenol 0.01 0.25 NA 0.1 0.8 NA 
*Relative to the activity of the enzyme with salicylate as a substrate 
** Measured at 370 nm (ε=2600 M-1cm-1)79 instead of 340 nm (ε=6200 M-1cm-1) 
Rates denoted as (-) were not tested with the specific enzyme. 
Rates denoted  as (NA) represent negative values 
Table 3.11: Substrate specificities of putative salicylate hydroxylases.  All above measurements 
represent duplicate averages in which background NADH consumption was subtracted.  All 
replicate measurements had a maximum difference of 5 %. Detailed reaction conditions are 




3.2.2.6 Measuring efficiency of substrate hydroxylation 
 After the 3 enzymes' most active substrates according to NADH consumption (Table 
3.11) were determined, a similar assay assessing the amount of oxygen uncoupled (proportion of 
oxygen used to produce H2O2 instead of hydroxylated product) was performed.  In this assay, 
reaction components were mixed in a sealed oxygen electrode chamber to measure the 
concentration of oxygen over time.  The putative salicylate hydroxylase was added and the 
decrease in oxygen concentration was observed until it plateaued, indicating that all the NADH 
was consumed.  At this point, catalase was added, and resulted in an increase in oxygen 
concentration due to the conversion of H2O2 to O2 (Figure 3.10). The oxygen uncoupling was 
then determined by comparing the oxygen consumed compared to the oxygen returned by 
catalase, where enzymes with the lowest amount of oxygen uncoupled were more efficient at 
hydroxylating their substrate.  Below in Table 3.12 is the oxygen uncoupling for the three 
purified enzymes with their most active substrates.    A. niger 767 is highly uncoupled with all 
substrates except 4-methoxysalicylate (43.7 %), whereas A. niger 577 has low uncoupling with 
most substrates tested including salicylate.  A. niger 534 is highly uncoupled with all the 
aromatic substrates tested.   
    
Figure 3.10: Example of oxygen uncoupling assay using A. niger 767 with salicylate. Reaction 





  Oxygen uncoupled (%) 
Substrate A. niger 767 A. niger 577 A. niger 534 
Salicylate  85.4 4.7 98.6 
3-methylsalicylate 91.2 58.1 - 
4-methylsalicylate 77.3 2.5 76.6 
5-methylsalicylate 90.3 13.4 91.1 
6-methylsalicylate 84.4 40.1 - 
4-methoxysalicylate 43.7 47.1 95.4 
2,3-dihydroxybenzoic acid 101 10.2 88.7 
2,4-dihydroxybenzoic acid 93.0 28.2 88.4 
2,5-dihydroxybenzoic acid 89.8 14.2 - 
2,6-dihydroxybenzoic acid 87.8 0.93 71.6 
3-chlorosalicylic acid 95.6 24.9 - 
4-chlorosalicylic acid 93.7 3.74 86.3 
5-chlorosalicylic acid 95.8 5.17 86.2 
Table 3.12: Oxygen uncoupling of salicylate hydroxylases.  Oxygen uncoupling measured in an 
oxygen electrode at 25 
o
C in 50 mM Tris-HCl pH 7.6 buffer.  All measurements were carried out 
in either duplicates or triplicates with averages represented.  All replicate differences were within 
2 %.  Measurements denoted as (-) were not tested with the specific enzyme. 
3.2.2.7: Product studies  
 Once the optimal hydroxylase enzyme substrate was determined by considering both 
enzyme activity and oxygen uncoupling, the products of the reactions were examined.  This was 
performed by using a coupled assay in which the hydroxylation product catechol (or a 
methylcatechol) was cleaved by catechol 2,3-dioxygenase (gift of Dr. Elisabeth Cadieux).  These 
cleaved products absorb at 400 nm and extinction coefficients are known.   A. niger 767 and 577 
both formed catechol and 4-methylcatechol using salicylate and 5-methylsalicylate as substrates, 
respectively.  Additionally, both enzymes produced 4-methylcatechol using 4-methylsalicylate as 
a substrate.  A. niger 577 appeared to produce 3-methylcatechol with 3-methylsalicylate and 6-
methylsalicylate as substrates, while A. niger 767 did not.  A. niger 534 apparently did not 
produce any catechol (or catechol-like) product with any of the substrates tested.  Additionally, 
some enzyme reaction products were detected using TLC such as the example of A. niger 577 
conversion of salicylate to catechol (Fig 3.11). 
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Salicylate 85.4 Yes 4.7 Yes 98.6 No 
3-methylsalicylate 91.2 No 58.1 Yes NA NA 
4-methylsalicylate 77.3 Yes 2.5 Yes NA NA 
5-methylsalicylate 90.3 Yes 13.4 Yes 91.1 No 
6-methylsalicylate 84.4 No 40.1 Yes NA NA      
* observable product refers to the formation of catechol or methylcatechol which is produced by 
the hydroxylase enzyme and cleaved by catechol 2,3-dioxygenase. 
Table 3.13: Formation of catechol or catechol-like products via 3 hydroxylase enzymes.  Assays 
performed as described in Materials and Methods.  Measurements denoted as NA were not 
tested with the specific enzyme. 
     
Figure 3.11: Identification of A. niger 577 reaction products by TLC in 50:50:1 (ethyl acetate: 
chloroform: acetic acid) developing solvent where salicylate, catechol, and the salicylate reaction 
product have been spotted in lanes 1, 2, and 3 respectively.  
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3.2.2.8: Substrate binding studies 
 Tightness of substrate binding to the A. niger hydroxylases was determined by measuring 
the change in fluorescence associated with the enzyme-bound FAD upon the addition of 
aromatic substrates.  Excitation was carried out at 450 nm which resulted in emission at 525 nm.  
The data were fit to the Hill1 equation in OriginLab as described in Materials and Methods.  In 
comparing binding of salicylate to A. niger 767 and 577 it was found that A. niger 577 binds 
salicylate nearly 4 times more tightly than A. niger 767, with apparent Kd values of 480 μM and 
95 μM respectively.  Additionally, the n values (Hill coefficients) for the fitted curves in Figure 
3.12 was about 1.   On the other hand, A. niger 767 binds 4-methoxysalicylic acid nearly 4 times 
tighter than salicylate with apparent Kd values of 98 μM for 4-methoxysalicylic acid and 480 
μM for salicylate (Fig 3.13).  (Some raw fluorescence data have been included in the appendices) 
 
Figure 3.12: Determination of salicylate binding to A. niger 767 (A) and A. niger 577 (B) Kd 
values by monitoring FAD florescence changes at λex =450 nm and λem= 525 nm.  Successive 
amounts of salicylate were titrated into a fluorescence cuvette containing 5 μM A. niger 767 or 




Figure 3.13: Kd determination for 4-methoxysalicylic acid binding to A. niger 767 (5 μM) by 
measuring changes in FAD fluorescence at λex =450 nm and λem= 525 nm with varying additions 















3.3 Phenol Hydroxylases  
3.3.1 PCR amplification to purification 
 Predicted phenol hydroxylase gene sizes and calculated protein sizes are listed in Table 
3.14: protein molecular weight is estimated based on the amino acid sequence submitted to the 
ProtParam server.  Table 3.15 summarizes the success of each of the experimental steps for these 
targets starting from PCR amplification and continuing through to characterization.  Expressing 
these target proteins proved very challenging, and was successful only with A. niger 999.  A. 
niger 687 could not be amplified by PCR while A. niger 422 did not produce enough PCR 
product for cloning.  A. niger 300, 146, 718, and 951 were successfully cloned but transformants 
never expressed protein under the various conditions attempted.  On the other hand, protein 
expression was observed for A. niger 617 but it was present in inclusion bodies.   Targets where 
production of soluble protein was not possible were not pursued any further. 
A. niger JGI 
ID 
Expected gene size 
(base pairs) 
Expected protein molecular weight 
(kDa) 
1206422 1809 67.0 
1210999 1977 73.2 
52617 1701 63.0 
1125300 1911 71.0 
1125146 1857 69.4 
1159718 1734 64.1 
1227951 1887 71.4 
1085687 1812 67.4 












Cloning Expression Purification Characterization 
1206422         
1210999     
52617        
1125300        
1125146        
1159718        
1227951        
1085687          
Table 3.15: Summary of steps achieved for each putative phenol hydroxylase target . Check 
mark () indicates successful step, () indicates unsuccessful step, and a blank box indicates 
untested step. 
3.3.1.1 PCR amplification of phenol hydroxylase target sequences 
 DNA fragments were amplified by PCR using the same set of conditions used for 
salicylate hydroxylase gene amplification (see section 3.2.1.1).  Figure 3.14 shows the PCR 
amplification results for A. niger 422, 999, 300, 146, 617, 718, and 951: all amplified fragments 




Figure 3.14: PCR amplification of A. niger putative phenol hydroxylase genes.  In all 4 gels 
DNA size markers are present in lanes on the far left.  The agarose gels show samples from the 
PCR amplification of A. niger 422 (A), 999 (B), 300 (C) 146 (D lane 2), 617 (D lane 3), 718 (D 
lane 4), and 951 (D lane 5).  Arrows pointing to size marker bands represent base pair sizes.  




3.3.1.2 Cloning, plasmid screening, and DNA sequencing 
 Amplified phenol hydroxylase target DNA sequences were cloned into the pLATE11 
vector, generating plasmids whose inserts were screened using restriction enzyme digestion and 
PCR experiments similar to those described in section 3.2.1.2 for salicylate hydroxylases (data 
not shown).  Then, all plasmids were sequenced and confirmed to contain the expected JGI target 
sequences, with the exception of A. niger 146 and 951 which contained introns as shown in 

































































Figure 3.16: Sequenced A. niger 951 plasmid construct where introns are highlighted in red 
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3.3.1.3 Protein expression results for putative phenol hydroxylases 
 Protein expression in different E. coli strains, at 16 
o
C was attempted for all successful 
phenol hydroxylase plasmid constructs (A. niger 999, 617, 300, and 718).  The only two proteins 
that were successfully expressed, as indicated by the appearance of the appropriately-sized bands 
on SDS-PAGE gels, are shown in Figure 3.17.  A. niger 617 was expressed in the pellet fraction 
in all E. coli strains tested (BL21 DE3, Rosetta DE3, and Shuffle) while A. niger 999 was 
expressed in the soluble cell fraction in BL21 (DE3).  Higher levels of A. niger 999 expression 
were observed  in Rosetta (DE3) E. coli as opposed to E. coli BL21 (DE3). 
 
Figure 3.17: Phenol hydroxylase expression trials (induction at 16 
o
C).  10% SDS-
polyacrylamide gels of: A. niger 617 in E. coli BL21 (DE3) (A); A. niger 999 in E. coli BL21 
(DE3) (B); and A. niger 999 in E. coli Rosetta (DE3) (C).  Lanes labelled Mw, S, and P represent 
molecular weight markers, supernatant (soluble cell fraction), and pellet (insoluble cell fraction) 
respectively.   Lanes with a negative sign (-) indicate uninduced cells while a positive sign (+) 
indicates that the cells were induced with 0.5 mM IPTG (at 16 
o
C).  Arrows indicate estimated 
protein sizes.  
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3.3.1.4 Purification of A. niger 999 
 A. niger 999 (73.2 kDa) was the only expressed and soluble phenol hydroxylase target 
obtained.  It was purified via a 4-step procedure as described in Materials and Methods.  
Samples from each step of the purification were run on a 10 % SDS-polyacrylamide gel, from 
which it is clear that a significant improvement in purity was obtained, compared to the crude 
extract (Fig 3.18). However, by comparing specific activities at each step of the purification, 
little change is observed (Table 3.16). 
   
Figure 3.18: Purification of A. niger 999 as monitored on a 10 % SDS-polyacrylamide gel. 
Protein low molecular weight markers (lane 1); crude extract (lane 2); empty (lane 3); DEAE 
pool (lane 4); ammonium sulfate concentrated DEAE pooled fractions (lane 5); phenyl-

































31.0 18.8 18.7 582 579 0.995 1.01 46.3 
phenyl-
Sepharose 
9.50 26.1 20.4 248 194 0.780 0.79 15.5 
Sephacryl S-
300 
7.50 29.9 32.4 224 243 1.08 1.10 19.4 
*One unit (U) is defined as the amount of enzyme required to oxidize one μmol/min of NADPH 
in the presence of phenol in 50 mM Tris-HCl pH 7.6 at 25 
o
C. 
Table  3.16: Purification summary for A. niger 999  
3.3.2 Phenol Hydroxylase: Characterization  
3.3.2.1: UV-VIS spectral properties of A. niger 999 
 The absorbance of purified A. niger 999 was measured over a range of 250 nm to 500 
nm, and the resulting spectrum is shown in Fig 3.19.  The characteristic peaks at 280 nm, 375 
nm, and 450 nm for amino acid and flavin absorbances previously described for the putative 
salicylate hydroxylases (section 3.2.2.2) are also present in this enzyme.  The flavin moiety was 
determined to be FAD by TLC (Fig 3. 20) while the FAD to protein ratio was  determined  to be 
0.62 after FAD addition, using the same methodology described in section 3.2.2.3.  As with all 
the other hydroxylase enzymes investigated addition of FAD to the crude extract resulted in 
increased activity.   
 
Figure 3.19: UV-VIS Absorbance spectrum of purified A. niger 999 and released flavin in 50 




Figure 3.20: Identification of A. niger putative phenol hydroxylase flavin by TLC.  FMN (lane 
1); FAD (lane 2); and A. niger 999 flavin (lane 3).  Samples were  developed on a Whatman 
silica-coated TLC plate using a developing solvent of n-butanol: acetic acid: H20 (4:1:5)
60
, and 
visualized under UV light. 
3.3.2.2 Oligomeric state of A. niger 999 
 The estimation of A. niger 999 molecular weight and oligomeric state was carried out 
using data from chromatography on a calibrated Superdex 200 10/300 GL gel filtration column, 
as described for the putative salicylate hydroxylases in section 3.2.2.4.  The estimated molecular 
weight of 132.9 kDa suggests that A. niger 999 is dimeric based on the predicted monomeric 










3.3.2.3 Nucleotide cofactor preference of  A. niger 999 
 NADPH was found to be a preferred co-substrate compared to NADH in the presence of 
phenol, as shown in Table 3.17. 
A. niger JGI ID 
Rate of NADH 
consumption 
(μmol/min/mg) 
Rate of NADPH 
consumption 
(μmol/min/mg) 
 NADPH / NADH 
999 0.19 1.09 5.7 
Table 3.17: Relative rates of A. niger 999 with NADH and NADPH.  Assays were done using 
phenol as a substrate by measuring the rate of NAD(P)H consumption at 340 nm.  Measurements 
were performed in duplicate with averages represented: background NAD(P)H consumption has 
been subtracted. 
3.3.2.4 A. niger 999 substrate specificity 
 The enzyme activity was measured with phenol and some of its derivatives, as well as  
other aromatic ring compounds.  A. niger 999's greatest activity was observed on hydroquinone, 
phenol, resorcinol, and p-cresol, which all exhibited similar specific activities, 4.18, 3.54, 3.38, 
and 3.11 (μmol/min/mg) respectively.   
Substrate 
Rate of NADPH Consumption 
(μmol/min/mg) 
*Relative Activity (%) 
Phenol 3.54 100 
o-cresol 0.09 2.5 
m-cresol 0.91 25.8 
p-cresol 3.11 87.9 
resorcinol 3.38 95.4 
phloroglucinol 0.14 3.9 
4-nitrophenol 0.15 4.1 
hydroquinone 4.18 118.1 
catechol 0.98 27.6 
* Relative to the activity of A. niger 999 with phenol as a substrate 
Table 3.18: A. niger 999 aromatic substrate specificity in the presence of NADPH.  Rate 
measurements were performed at 340 nm, in duplicate: background NADPH consumption was 
subtracted and replicate measurements differed by a maximum of 5 %. 
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3.3.2.5 Measuring hydroxylation efficiency of putative phenol hydroxylase, A. niger 999 
 Oxygen uncoupling in A. niger 999 with the four most active aromatic substrates was 
measured using an oxygen electrode, as described in Materials and Methods.  Activity in the 
presence of, phenol was the most uncoupled, with 32.1 % of the O2 consumed diverted to 
hydrogen peroxide formation. On the other hand, p-cresol, resorcinol, and hydroquinone 
exhibited significantly lower oxygen uncoupling, with values of 5.49 %, 4.12 %, and 5.34 %. 






Table 3.19: A. niger 999 oxygen uncoupling with the most active phenolic substrates.  All 
measurements were carried out in duplicate or triplicate, with averages shown.  All replicate 
differences were within 5%. 
3.3.2.6 A. niger 999 product identification with selected aromatic ring-substrates  
 Product formation was examined using the most active aromatic substrates, phenol, p-
cresol, resorcinol and hydroquinone.  Product identification proved possible by coupling catechol 
2,3-dioxygenase to A. niger 999 in these assays, as described in Materials and Methods.  This 
enzyme was tested to cleave catechol, 4-methylcatechol, and hydroquinone which results in a 
yellow product (2-hydroxymuconate semialdehyde or a derivative depending on the initial 
substrate) which absorbs at 400 nm (data not shown).  Additionally, catechol 2,3-dioxygenase 
does not appear to cleave pyrogallol or phloroglucinol (when measuring absorbance at 400 nm, 
data not shown).  All 4 of these substrates for A. niger 999, when turned over in the presence of 
catechol 2,3-dioxygenase, resulted in the appearance of an intense yellow color absorbing at 400 
nm (data not shown).  This is consistent with conversion of phenol to catechol, p-cresol to 4-























Figure 3.21: A. niger 999 product formation. Phenol to catechol (a), p-cresol to 4-methylcatechol 












3.4 2,3-dihydroxybenzoate decarboxylase (A. niger 716) 
 In addition to the aromatic ring-hydroxylases, other enzymes are involved in preparation 
of some aromatic compounds for ring cleavage dioxygenases.  One such group of enzymes are 
the aromatic ring decarboxylases. Here, I will present results obtained for the A. niger 2,3-
dihydroxybenzoate decarboxylase, which has previously been studied by Rao et al. (1967)
2
 and 
Kamath et al (1987)
4
.  In their studies the enzyme was isolated from its native organism A. niger, 
while here the enzyme was cloned and expressed in E. coli.   
3.4.1.1 PCR Amplification of A. niger 716 
 PCR amplification was carried out using the same procedures as described for salicylate 
and phenol hydroxylase target genes (section 3.2.1.1 and 3.3.1.1).  This enzyme is predicted to 
have a DNA gene size of 1029 bp and a corresponding protein molecular weight of 39.2 kDa.  
The amplified DNA fragment appears to be of the correct size (Fig 3.22). 
 
Figure 3.22: PCR amplification of A.niger 716 run on a 0.8 % agarose gel.  Numbers pointing to 
bands represent base pair sizes. 
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3.4.1.2 2,3-dihydroxybenzoate decarboxylase plasmid insert verification 
 After LIC cloning of the successfully-amplified DNA target into the pLATE11 plasmid, 
as described in Materials and Methods, the recombinant plasmid was examined by restriction 
digest analysis and DNA sequencing to determine whether it contained the correct DNA insert.  
For restriction digest analysis, the recombinant plasmid was cleaved using KpnI, for which there 
is one cut site in the gene and another in the pLATE11 plasmid (Fig 3.23).  KpnI cleavage of the 
plasmid resulted in bands of 315 bp and 5166 bp, which were observed on an agarose DNA gel  
(Fig. 3.24).  DNA sequencing further confirmed that the target sequence (A. niger 716) was 
indeed cloned correctly into the recombinant plasmid used for expression.  
 
Figure 3.23: A. niger 716 restriction digest map using KpnI. pLATE11 derived DNA is shown in 




Figure 3.24: Restriction digest of recombinant A. niger 716 plasmids with KpnI cleavage, 
followed by electrophoresis on a 1.0% agarose gel.  Base pair sizes are indicated with arrows, in 
lane 1.  Lanes 3-10 represent samples of 4 recombinant plasmids each isolated from independent  
single colonies (numbered 1-4), where U indicates uncut plasmid while C indicates KpnI treated 
plasmids.  Transparent circles highlight bands which are barely visible, representing the smaller 
band (≈ 315 bp) .  
3.4.1.3 A. niger 716 protein production 
 The recombinant plasmid was introduced into E. coli BL21 (DE3), and protein 
expression was monitored using SDS-PAGE.  As shown in Fig 3.25, a protein of the expected 
size (39.2 kDa observed, vs. 39.5 kDa theoretical size) was successfully expressed in the soluble 







Figure 3.25: A. niger 716 protein expression in E. coli BL21 (DE3) at 16 
o
C as monitored by 
SDS-PAGE.  Lanes labelled Mw, S, and P indicate lanes that have been loaded with protein 
molecular weights, lysed cell supernatant and pellet, respectively.  (-) and (+) signs represent 
samples from uninduced and induced (0.5 mM IPTG) cell cultures, respectively.   
3.4.1.4 A. niger 2,3-dihydroxybenzoate decarboxylase purification 
 A. niger 716 was partially purified via a 3-step purification procedure consisting of ion-
exchange chromatography, hydrophobic interaction chromatography, and size-exclusion 
chromatography.   Samples from each purification step were run on a 10 % SDS-polyacrylamide 
gel (Fig 3.26), which shows that some contaminants were removed and the purity of the final 
preparation was improved compared to the initial crude extract.  However, little change in the  




Figure 3.26:  A. niger 716 protein purification - fractions analyzed by SDS-PAGE.  Samples are: 
protein low molecular weight markers (lane 1); crude extract (lane 3); pooled DEAE fractions 
(lane 5); pooled phenyl-Sepharose fractions (lane 7);  and pooled Sephacryl S-300 fractions (lane 




























16.6 50.0 831 64.1 3.20E+3 3.85 1.31 58.2 
PS 30.4 11.5 350 77.7 893 2.55 0.87 16.2 
S-300 (pure) 81.4 2.50 203 248 619 3.04 1.03 11.3 






3.4.2.1 pH-activity profile of A. niger 716  
 The enzymatic activity of A. niger 716 at 25 
o
C was scanned across various pH values to 
determine the pH optimum of the enzyme using 2,3-dihydroxybenzoate (2,3-DHB) as a 
substrate.  Some overlapping pH values were tested to determine whether the buffering system 
influenced the enzymatic activity.  The pH optimum was found to be around 6.0 while surveying 
the wide range of pH values shown in Fig 3.27A, while in Fig 3.27B the use of a much narrower 
pH range with more data points established a pH optimum of 6.2.   
 
Figure 3.27: A. niger 716 activity as a function of pH over wide (A), and narrow (B) ranges.  
Buffers were 20 mM sodium acetate (pH 4.8-5.9), 20 mM PIPES (pH 6.0-7.2), 20 mM Tris (pH 
6.9-9) for panel A and 20 mM Bis-tris was used for all buffers in panel B.  Data were obtained in 









3.4.2.2 A. niger 716 substrate specificity 
 As was shown previously using enzyme purified from the native A. niger host
4
, the 
recombinant enzyme was specific for 2,3-dihydroxybenzoate decarboxylation: all other tested 
substrates showed activities less than 2 % (Table 3.21).    
Substrate  
Substrate consumption  
(µmol/min/mg) 
Relative 
activity* (%)  
2,3-dihydroxybenzoic acid 3.72 100.0 
2,4-dihydroxybenzoic acid 0.01 0.4 
2,5-dihydroxybenzoic acid - - 
2,6-dihydroxybenzoic acid 0.02 0.5 
3,4-dihydroxybenzoic acid 0.06 1.7 
Salicylate - - 
3-hydroxybenzoic acid 0.00 0.0 
Anthranilic acid - - 
* relative to 2,3-dihydroxybenzoic acid activity  
- no activity 
Table 3.21:  A. niger 716 activity on different aromatic substrates.  Reported activities are 
averages of duplicate measurements with a maximum difference of 5 %. 
3.4.2.3: Oxygen sensitivity and reversibility of A. niger 2,3-dihydroxybenzoate 
decarboxylase 
 The activity of the enzyme was tested to see if reducing agents affected its activity since 
many aromatic-ring decarboxylases, such as 3,4-dihydroxybenzoate decarboxylase from 
Clostridium hydroxybenzoicum JW/Z-1T, are sensitive to O2
41
.  Table 3.22 shows that the 
activity was unaffected by the presence of 1 mM DTT in the assay.  Furthermore, pre-incubation 
of the enzyme with 10 mM DTT for 10 min did not have a significant effect on the activity in 
comparison with a control sample diluted appropriately with buffer.   
 The enzymatic carboxylation of catechol to 2,3-dihydroxybenzoate  was also examined in 
the presence and absence of reducing agent since many aromatic-ring decarboxylases are also 
sensitive to oxygen for the reverse reaction
41
.  Carboxylation occurred when the enzyme was 
added to catechol and CO2 supplemented by potassium bicarbonate, as shown in Table 3.23.   
Similarly to the decarboxylation reaction, the carboxylation reaction is oxygen insensitive since 
similar rates are observed with and without DTT.   
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Condition Relative Activity* (%) 
No DTT 100.0 
Assay with DTT (1 mM) 101.6 
Incubated with DTT (10 mM) 83.5 
Dilution Control 80.8 
* relative activity compared to activity in the absence of DTT  
Table 3.22:  2,3-Dihydroxybenzoate decarboxylase activity in the presence and absence of DTT.  
When enzyme was pre-incubated with 10 mM DTT, addition of a 1 in 10 volume resulted in the 
presence of 1 mM DTT in the assay.  The dilution control was when the same volume of enzyme 
was added with no DTT to account for enzyme dilution effects.  Measurements above are 
averages of duplicates, which vary by a maximum of 5 %. 
Assay with  
Rate of 2,3-Dihydroxybenzoate formation 
(µmol/min/mg) 
  No DTT With DTT 
No KHCO3 0.0258 0.0099 
No Enzyme 0.0092 0.0040 
0.25 M KHCO3 0.1170 0.1284 
Table 3.23:  Reversibility of A. niger 716 catalyzed decarboxylation of 2,3-dihydroxybenzoate 
decarboxylase in the presence and absence of DTT.  Reactions were performed in 100 mM 
phosphate buffer pH 6.8 with 300 µM catechol at 25 
o
C  Values represent duplicate averages 
which had a maximum difference of 2%. 
3.4.2.4 Oligomeric state of A. niger 2,3-dihydroxybenzoate decarboxylase 
 Protein molecular weight and oligomeric state were determined for the A. niger 2,3-
dihydroxybenzoate decarboxylase in the same manner as the putative salicylate and phenol 
hydroxylases on the calibrated Superdex 200 10/300 GL gel filtration column (section 3.2.2.4 
and 3.3.2.2).  The eluted protein was estimated to have a molecular weight of 122.4 kDa, which 
corresponds to a trimer based on the 39.2 kDa predicted monomeric molecular weight.  The 





3.4.2.5 Effects of metals ions on A. niger 2,3-dihydroxybenzoate decarboxylase activity  
 Since similar decarboxylase enzymes, such as 2,6-dihydroxybenzoate decarboxylase 
from Rhizobium sp
39
, have been reported to be metal-ion dependant, the effects of metal ions on 
A. niger 2,3-dihydroxybenzoate decarboxylase activity was examined.  Prior to assaying the 
enzyme it was incubated in various metal ions.  None of the metal ions resulted in increased 
activity, however, zinc, copper, and cobalt had inhibitory effects on the enzyme (Table 3.24).  
 The amount of each individual metal ion bound to the purified enzyme was determined 
by ICP-MS both before and after chelator treatment.  Samples were prepared for analysis as 
described in "Materials and Methods", including appropriate buffer controls.  A standard curve 
was prepared for each metal (see Appendix).  Of all the metals examined only magnesium and 
calcium were detected in the purified enzyme, albeit in sub-stoichiometric amounts (Table 3.25).  
Enzyme samples were also treated with a mixture of two chelators, EDTA and 8-
hydroxyquinoline-5-sulfanilic acid, prior to metal analysis, in an effort to remove any metal ions 
present (procedure adapted from Atkin et al, 1973
67
).  After chelation treatment, magnesium was 
present (Table 3.26) at similar sub-stoichiometric levels as prior to chelation.  Calcium levels 
appeared to be below 0 ppb, a result of the fact that buffer control had a higher calcium 
concentration than the sample.  The reason for this has not been determined. 
 The enzyme samples treated with chelators were examined for activity in the presence of 
various metal ions.  As shown in Table 3.27 only a small possible difference in activity was 
observed after chelation supplementing the enzyme with Ca
2+
 revealed that there is a increase in 
the enzymatic activity after incubation with Ca
2+
, and a decrease upon Mg
2+





























*relative activity represents activity compared to that with no metal 
Table 3.24: Effects of metal ion additions to A. niger 716 prior to activity assay.  A. niger 716 
was incubated with 5 mM metal ion for 10 min before being assayed.  Reported values represent 








Mg 310 117.6 ± 0.5 37.9  
Ca 510 84.8 ± 12.3 16.6  
Mn 700 14.2 ± 0.1 2.0  
Fe 715 18.9 ± 0.2 2.6 
Co 750 0.1 ± 0.001 0.0 
Ni 752 3.6 ± 0.1 0.5 
Cu  810 1.4 ± 0.01 0.2 
Zn 835 20.1 ± 0.3 2.4 
* Theoretical [metal] is based on a 1:1 metal to enzyme ratio 
Table 3.25: ICP-MS metal analysis of A. niger 716.  0.5 mg of purified protein was subjected to 
nitric acid digestion and the resulting supernatant analyzed by ICP-MS.  A buffer control was 














Mg 310 93.8 ± 0.4 30.3 
Ca 510 -140.0 ± 4.7 -27.5 
Mn 700 14.2 ± 0.1 2.0 
Fe 715 8.2 ± 0.4 1.1 
Co 750 0.1 ± 0.002 0.0 
Ni 752 1.7 ± 0.05 0.2 
Cu  810 -3.3 ± 0.015 -0.4 
Zn 835 5.5 ± 0.1 0.7 
* Expected [metal] is based on a 1:1 metal to enzyme ratio 
Table 3.26: ICP-MS metal analysis of A. niger 716 samples after chelation with EDTA and 8-
hydroxyquinoline-5-sulfanilic acid.  0.5 mg of protein was subjected to nitric acid digestion and 
the resulting supernatant analyzed by ICP-MS.  A buffer control was prepared and measured in 
the same manner as the protein sample and its metal content was subtracted. 
A. niger 716 Sample 




No chelator 4.42 100 
Chelator treated 4.13 93.3 
CaCl2 supplemented 7.02 159 
MgCl2 supplemented 3.11 70.3 
*relative activity compares the activity without metal addition and before chelation 
Table 3.27: Effects of MgCl2 and CaCl2 supplementation on A. niger 716 activity after chelation.  
Metal supplemented samples containing A. niger 716 were incubated in buffer containing 5 mM 
MgCl2 or CaCl2 for 5 min before being assayed.  Assays were performed in duplicate, with a 
maximum difference of 5%, with averages shown.  The activity of chelated sample is corrected 







3.5  Bioinformatic Studies 
3.5.1 Comparison of putative salicylate hydroxylase sequences 
 Figure 3.28 presents the amino acid sequence alignments of all target A. niger salicylate 
hydroxylases. Alignments were generated using the ClustalOmega sequence alignment tool
72
, 
with important residues that have been manually highlighted.  The characterized E. festucae and 
P. putida salicylate hydroxylases sequences have been included to serve as a model for 
comparing the putative A. niger salicylate hydroxylases.  In general, residues are well conserved 
in all regions including the FAD fingerprint (yellow highlight) and FAD and NADH binding site 
regions (pink), which is consistent with the data shown in the preceding sections that these 
enzymes are all flavoproteins that use NAD(P)H.   The substrate active site motif (grey 
highlight) is reasonably well conserved as well.  Differences in the sequences are apparent in  the 
region with the potential catalytic serine residue (green).  
E.fest              ----------MATKKDHVFAIIGGGIAGLTLAVALHH----RGLRIKIFEQAGQMQEIGA 46 
P.putida(5EVY)      ------------SKSPLRVAVIGGGIAGTALALGLSKS---SHVNVKLFETAPAFGEIGA 45 
P.putida23262       ---------MKNNKLGLRIGIVGGGISGVALALELCRY---SHIQVQLFEAAPAFGEVGA 48 
JGI577              ---------MSPSKKDFHVAIIGGGIAGVTLAIALHH----RNIPVTIYEQAHEFGEVGA 47 
JGI767              -------MTVSNNDKPLRIAIVGGGIAGVTLLLALLKHTSRQNIAPHLYEATPEFSEIGA 53 
JGI534              MAQPAASISGQAGSDTMHIAIVGAGIGGLALAIGLTN----RGVSYTLYESAAQFSAVGA 56 
JGI655              -----------MSTDSIEVAIIGAGITGITLALGLLS----RGIPVRVYERARDFHEIGA 45 
JGI860              ----------MGPPRPFTVTIIGGGIGGLVLAVGLLR----RQVPVQIYEAAAAFAEIGL 46 
JGI684              ---------MEQAKTPLQVIVVGAGIGGMAAALTLGL----RGHHVTILESAPKLMEVGA 47 
                                      . ::*.** * .  : *            : * :  :  :*  
 
E.fest              GVAFTPNALQAMRVCHPAIYEAYERVRT--RNL--WPCKQKVWFDFYDTRNEDG---D-A 98 
P.putida(5EVY)      GVSFGVNAVEAIQ--RLGIGELYKSVADSTPA-----PWQDIWFEWRHAHDASL------ 92 
P.putida23262       GVSFGPNAVRAIV--GLGLGEAYLQVADRTSE-----PWEDVWFEWRRGSDASY------ 95 
JGI577              GVSFSPNAVQAMKYCHEGIHNAFEKVCT--RNL--WPTKQKVWFDYLDGYNHKESPQN-G 102 
JGI767              GIAFGSNSIRAMELIDSGLAAAYNQHATFQPDT--GALDKKLWSSYRMGMDGRGPPSNSL 111 
JGI534              GIGLGPNALHAMELIDTRFRQLYNQISSGNLT----PNKEHIAMEVLYAEEGFGAKRG-W 111 
JGI655              GIGFTPNAEWAMKVVDPRIQAAFKRVAT--PN-------ASDWFQWVDGFNESGTDPRET 96 
JGI860              GLSIGPAAHRAMPLIDPEIRAIYDALVTTHADSPGYERYKQTWFELVWATGDH------- 99 
JGI684              GIQVSPNMLTLFDRWGVSPLIHAQDVALEHIH-------V---RRWEDGSMLGT------ 91 
                    *: .       :                                                 
 
E.fest              AAKPAFTI-SNDVGQNGVLRAHFLDELIKLVPRE--AAHVGKRLASYEEGGPD-GRLRLR 154 
P.putida(5EVY)      ----VGATVAPGIGQSSIHRADFIDMLEKRLPAG--IASLGKHVVDYTENAEG---VTLN 143 
P.putida23262       ----LGATIAPGVGQSSVHRADFIDALVTHLPEG--IAQFGKRATQVEQQGGE---VQVL 146 
JGI577              RQNIEFTI-SNSLGQNGVHRAHFLDELIKLVPKE--ISRFNKRLEDIHERISD-GKLIMK 158 
JGI767              KAGDYLHEVHAPVARSSVHRARFLEAMTALLPPEGGFVSFGKRLVSIEEGADG---ATVH 168 
JGI534              QPAPFG---AEFYTRTSAHRRDLLEIMTSLIPQE--RVQFNKRVKHINQTGEN-SKIIIT 165 
JGI655              EEQLLFKIYLGERGFEGCHRADFLGELARLLPEG--VVTFQKALDTVEPAADNSLGQLLR 154 
JGI860              EGETLMDLKALPSGQTTLRRADFLAALVALVPPE--IVHFGKRLNQLAETADG---VRLQ 154 
JGI684              -----LPVNKTYGQQTVIHRADLHNALIEKALA---LSNVELRVNSTVTGV-QFDHAAVQ 142 
                                       *  :   :            .                  :  
 
E.fest              FADGSEDEADVILACDGIKSRVRQLLFG-AHHPCALPSYTHRYAYRALVPMEEAVDA--- 210 
P.putida(5EVY)      FADGSTYTADVAIAADGIKSSMRNTLLRAAGHDAVHPQFTGTSAYRGLVETSALREAYQA 203 
P.putida23262       FTDGTEYRCDLLIGADGIKSALRSHVLEGQGLAPQVPRFSGTCAYRGMVDSLHLREAYRA 206 
JGI577              FADGSEDVADLVIGCDGIKSQVRQIIVG-ADHPSAKPSYTHKYAYRGLVPMDKAVEA--- 214 
JGI767              FADGTSVVADAVLGCDGIKSRVRQILLE-GE-EAANAVFTGKYAYRGLIPMDEAVAA--- 223 
JGI534              FEDGSIAEADAVIGCDGVKGPTRQAVLGTLYPDKVQPIFSGKYVYRSIVPMEDAQRL--- 222 
JGI655              FQDGTTATAHAVIGCDGIRSRVRQILLG-EDHPTASAHYSHKYAARGLIPMDRAREA--- 210 
JGI860              FEDGTTAMADVVVGCDGIKSKVKESMLP-EESAVKQPRYSGMYGYRAVFDMDEMVAA--- 210 
JGI684              LANGTIVKGDIVIAADGIKSALRDHLLE----EASVAIPTGDAAYRIMLPRSALENDPEL 198 






E.fest              --IGKEKAQNAAMHMGKGGHVLTFPVNHGQTVNVVAFHATS----EEWPDSSKLTAQSTR 264 
P.putida(5EVY)      ASLDEHLLNVPQMYLIEDGHVLTFPVKKGKLIIIVAFVSDRSVAKPQWPSDQPWVRPATT 263 
P.putida23262       HGIDEHLVDVPQMYLGLDGHILTFPVRNGGIINVVAFISDRSEPKPTWPADAPWVREASQ 266 
JGI577              --IGEELASNSCMHMGPGGHMLTFPVNGGKTLNIVAFHTTT----DEWAEYPRLTRQGTR 268 
JGI767              --LGEYTARNNHFHWGYGGHLLTFPIEHGRTMNVVAFRTKD---NGVWEHGSQWVLPGNK 278 
JGI534              --LGDHAGDA-KAFVSHKKNIMTFPISRGTELNVVAIKMMD----GPWT-HPQWTKDVTK 274 
JGI655              --LGEDKVATRFMHLGPDAHALTFPVSHGSLLNVVAFVTDP----NPWPYADRWTAQGPK 264 
JGI860              --VGDQRARVSTMYLGKGAYAISYPIMRAKKVNFGLYILS-----ESWD-HDAWVRPASR 262 
JGI684              KALVDE--PQATRWLGPGRHVIAYPVRNHDLYNVVLLHPDSHG------VEESWTTKGSK 250 
                      : .                :::*:       .                    .      
 
E.fest              EAALRDFSNFGPGITKLLKLTSPK-LDIWAIFDLGENPPPTFA-MDRVCLVGDAAHATSP 322 
P.putida(5EVY)      DEMLHRFAGAGEAVKTLLTSIK-S-PTLWALHDFD--PLPTYV-HGRVALIGDAAHAMLP 318 
P.putida23262       REMLDAFAGWGDAARALLECIP-A-PTLWALHDLA--ELPGYV-HGRVVLIGDAAHAMLP 321 
JGI577              DEVLRDFAGYGPNVTMLLKLTDPQ-LSVWAIFDLGDHPVPTFY-KGRVGISGDAAHATSP 326 
JGI767              KQMLQDFEGWGPDVRAILSLMR-N-ADIWAMFEHA--PASTYHRGGRICLVGDAAHASTP 334 
JGI534              EEMVADFAEVDQHLLKLLDWAK---PLQWSLWHHP--DTPTYY-NGRICLLGDSAHGTTP 328 
JGI655              KDVTAAFSRFGPTMRTIIDLLPDP-IDQWAVFDTYDHPPNTYS-RGAVCIAGDAAHAAAP 322 
JGI860              EDMRRDAQGMGRYVQALVERMP-D-PSQWAIFEHP--HLSTYT-KSRVAILGDAAHASTP 317 
JGI684              QAMVDNYKGWDRRVTKLIDLVPDDEVLEWKLCLHA--PLKTWI-RGSVALIGDACHPMLP 307 
                              .     ::          * :          :   . : : **:.*   * 
 
E.fest              HHGAGAGFCIEDAAVLAHLLASEEISD----------HRGHRVALAVYDAVRRERGSWLV 372 
P.putida(5EVY)      HQGAGAGQGLEDAYFMAELLGNPLHEA-----------SDIPALLEVYDDVRRGRASKVQ 367 
P.putida23262       HQGAGAGQGLEDAYFLARLLGDTQADA-----------GNLAELLEAYDDLRRPRACRVQ 370 
JGI577              HHGAGAGFCIEDTAVLATLLEDERVQT----------HKDLQAVLAAFDENRRERSQWLV 376 
JGI767              HQGAGAGMAVEDVFVLSRLLGAVREK------------NDLVRAFVAYDAVRRPRTQELV 382 
JGI534              HQAAGAGQCLEDSLIMSHILGLAKNR------------SEITHAFQVYDSIRRPRAQAVV 376 
JGI655              HHGAGAGCGVEDAAVLCAVLHMAAKKVNTAKTGSEGKAALITAAFETYDSVCRERAQWLV 382 
JGI860              HQGAGAGQAIEDAHVLAELLSDPRVNS----------VDDVVNAFKAYDQVRRPRSQHVV 367 
JGI684              YVAQGAAQAVEDAAALGVLLSTISSR------------DEIPLALKAYEKSRKPRADTVQ 355 
                    : . **.  :**   :  :*                        : .::   : *   :  
 
E.fest              QSSRRIGDTYEWMAE--------------GIEDDLAKAEEEIKYRNGVIADVDVEAMCHQ 418 
P.putida(5EVY)      LTSREAGELYEYRTP--------------GVERDTAKLKALLESRMNWIWNYDLGAEARL 413 
P.putida23262       QTSWETGELYELRDP--------------VVGANEQLLGENLATRFDWLWNHDLDTDLAE 416 
JGI577              QSSRFIGDCYEWRAD--------------GVGSDFKKIEEAINYRNGVIANVDVGKMCEE 422 
JGI767              RTSRDAGMLYECQKE--------------GVWDNVDKIRENLDMRMRWIWDLNVEQHLQD 428 
JGI534              TTSQEAGTLYTFTHP--------------QLGTDLAEIVANLNQRFLWIWDHDLKADIEL 422 
JGI655              ESSRVIGNLYEWQDK--------------EVGSDASRCHDEVYWRSHRIWDYDIDAMMRE 428 
JGI860              TTSKENAYLLCLCLD--------------GVGDKEDKLRETFQQRLRWLWDLDVQEQAEQ 413 
JGI684              QSGSENRITLHLPDGPEQRARDEQFRSSLKSGSNPDRWTDLETQKFLWGWDAEKAAL--D 413 
                     :.                              .          :     : :        
 
E.fest              AREEFSKRWRAVG---------- 431 
P.putida(5EVY)      AVKPALA---------------- 420 
P.putida23262       ARA-RLGWEHGGGGA---LRQG- 434 
JGI577              AKGVLGRKIEKASL--------- 436 
JGI767              ALDIFHASS-------------- 437 
JGI534              ARRWFIALVQMSQSR---L---- 438 
JGI655              TAEVFEAQVAGVARN-------- 443 
JGI860              ARRKMFSECKL------------ 424 
JGI684              A------WNELHGNHVSELRHHL 430 
                    :                       
 
Figure 3.28:  Salicylate hydroxylase sequence alignments.  Alignments were generated using 
ClustalOmega
72
.  An asterix (*) represents conserved, a colon (:) strongly conserved, and a 
period (.) weakly conserved residues.   A. niger target sequences from this study and E. festucae 
and P. putida salicylate hydroxylase sequences have been included
33,80
.    Important residues 
identified in salicylate hydroxylases are highlighted; FAD fingerprint regions (yellow); NADH 
and FAD binding sites (pink); salicylate binding and active site (gray); potential catalytic serine 




3.5.1.1 Comparison of putative phenol hydroxylase sequences 
 The sequence alignment of the putative phenol hydroxylases is presented in Fig 3.29.  
The T. cutaneum sequence has been included since it is a known eukaryotic phenol hydroxylase 
that is induced by the growth of T. cutanueum on phenol, and is highly active and tightly coupled 
in turning over phenol compared with similar compounds
74,81
.  The alignment of key catalytic 
residues (Asp 54 and Tyr 289)  shows that in most of the sequences these residues are well 
conserved, but in some cases these residues are different and may lead to differences in 
enzymatic properties.  Additionally, residues that are part of the FAD fingerprint and Rossmann 
fold are all well conserved, as would be expected for NAD(P)H-dependent flavoproteins. 
PhenolHydroxylase_Tcutaneum      ---------------------------------MTKYSESYCDVLIVGAGPAGLMAARVL 27 
A_niger999                       MPVFTEYASKSRDLRVLPSFSLPVPRLTPPFEPTVNDGVERYEVVIVGAGPSGLMLELLL 60 
A_niger687                       --------------------------------MAPNSSPSQTDLLIIGAGPAGLMAACWA 28 
A_niger951                       ---------------------------------MTVSIESTTDVLIIGAGPSGLTIAYWM 27 
A_niger422                       -------------------------------------MTQKVDVLICGSGSAGLCAATWL 23 
A_niger146                       --------------------------MTIAPYPVGAFKSQRTDVLIVGAGPAGCMAAATL 34 
A_niger300                       ---------------------------------MAPSQQEKYDIVIVGAGPVGIVLSLCM 27 
A_niger617                       -----------------------------------MTEIKKTDVFISGGGPTGLLTAYAL 25 
A_niger718                       -----------------------------------MPSPETYDVTIIGGGPVGLLLAYQL 25 
                                                                        .  :: * *.*  *        
 
PhenolHydroxylase_Tcutaneum      SEYVRQKPDLKVRIIDKRS---TKVYNGQADGLQCRTLESLKNLGLADKILS-EANDMST 83 
A_niger999                       ARYGLS--DESLLCIDSKP---STLKSGQADGVQPRTLEVFKTLGISDEIEN-EACQMWQ 114 
A_niger687                       SQY----TNMTTRIIDKHP---SRTATGHADGIQSRTLEILESFGLVDPIVR-KGVQHAE 80 
A_niger951                       AQY-----GINARIIDKRS---TKLFRGHADGLRGRTLELIDSMGFVHRILQ-EGYHGAG 78 
A_niger422                       ARY-----GIKCKVLERRD---GPMTMGQADGVQCRTVEIFESFGIGEELLR-ESYHVVE 74 
A_niger146                       QRY-----GIDFCLIDKRP---TRTQTGHASAFQPRTQEILQTMNLLHDLDK-RGHRLTE 85 
A_niger300                       SRW-----GYKVKHIDNRP---VPTATGRADGIQPRSTEILRNLGLKRQIMAFKPAKVYD 79 
A_niger617                       ARQ-----GVDTLFVEQHDK-AQQAMYGRATTLHPRTLELLDQLSILDDLNQ-IGYVARD 78 
A_niger718                       SRF-----ELSVCVVEKQDKNSPEGRYGRAITLFPRTLELLDQLDLVHTMLQ-QGFACRS 79 
                                  .            :: :         *:*  .  *: * :  :.:   :           
 
PhenolHydroxylase_Tcutaneum      IALYNPDENGH-IRRTDRIPDTL-PGISRYHQV-VLHQGRIERHILDSIAEISDTRIKVE 140 
A_niger999                       FAFWNTSSDPSKIIERKSVVPEV-IPPARFRYEATIHQGRIERIMETDLLRYSKRGVQRG 173 
A_niger687                       MCFWGYDKNTG-GITRQKMDPAQ-TDKSRYNMV-LLNQGMIEQIILDYLELEREKRVEVE 137 
A_niger951                       LRYWRPDGKGG-LKRAGELRSTI-WNSSPYRMA-LF--------------------IDVE 115 
A_niger422                       VVFWADDSGSGVIRRTGKTADTQ-PGLSHQPHV-ILNQARINGLLIELMKKYNGQEIDYG 132 
A_niger146                       TSFWMRDSTGALISNFTGA--EV-VHATPYQYLFNTDQGMTEDVFEQYLNTK-GQKI--- 138 
A_niger300                       VAFWDPLPGGQDIHRTGSWPSCPRFIDTRYPFTTLVHQGKIERVFLDEIQKA-GTTVERP 138 
A_niger617                       SVTYRD---GKRVSSRGWEIMYQHMRGTFLDYCLNIRQKFSEEVIRDAYVSLRGEPYIGW 135 
A_niger718                       SVTYKD---GVRQFPGKVWTFMENIQGTVFDFALVLRQMYTEGILRKRLDKEKV-TYHGS 135 
                                    :                       :                                 
 
PhenolHydroxylase_Tcutaneum      RPLIPEKMEIDSSKAEDPEAYPVTMTLRYMSDHESTPLQFGHKTENSLFHSNLQTQEEED 200 
A_niger999                       TKLVHV------QLNEDDKEFPVLAEIE-------------------------------- 195 
A_niger687                       YAKQAKTLEF------LKDEYPIVVGVKRVG---------------------L------- 163 
A_niger951                       RGVIGESLSYDESLENDPQAYPITIKLRTLSEEEATPIPNPGITPYKPARDDL------- 168 
A_niger422                       YTVQDVRVD-ESQLSAGPEAYPVKVTAE-------------------------------- 159 
A_niger146                       ----QRFMELVHYEHDLDPEWPLTAYI--------------------------------- 161 
A_niger300                       WTIVGF------KNDGLDETYPVEVQLK-------------------------------- 160 
A_niger617                       -RLDGFT-----VEEACDDDYKVVSHVT-------------------------------- 157 
A_niger718                       MECVAFE-----IG-LDGSEYPVT--VH-------------------------------- 155 
                                                     : :                                      
 
PhenolHydroxylase_Tcutaneum      ANYRLPEGKEAGEIETVHCKYVIGCDGGHSWVRRTLGFEMIG-EQTDYIWGVLDAVPASN 259 
A_niger999                       ---------TRGVRRLIRTKHLVGADGAHSMVRQCMGLRLEG-QSLDHIWGVIDLVVDTN 245 
A_niger687                       ----DGANGHCDQVETIRARYVIGCDGARSWVREQLQVPMRV-CSGDTTWGVVDIAPITD 218 
A_niger951                       EDLVPKRKHDVGTIETVRAKYLIGCDGAHSWTRKQLNIPFEG-SHTDHIWGVMDVVPITD 227 
A_niger422                       ---------KDGKVESFEAKYALACDGAHSTVRKALGYNMIG-DSTDAVWGVMDMVPRTD 209 
A_niger146                       ------KNNASGAIEAWQTKYILGTDGARSATRRATGVQSSS-QGGEDVWAVADVYVDTN 214 
A_niger300                       -------SIDTNVIETVRTKYLFSGEGARSFIRQQLGIQIQYKDPISYVWGVMDGVVRTN 213 
A_niger617                       -------EVSSGRSLTVRSKFIVGADGSHSLVRRLAGIPFEG-DHTNFRWVRIDGRFKTD 209 
A_niger718                       -------CSGPGGMMTAKSKYLVGADGGHSLVRRYANIPFDG-DSSEDQWIRIDGIVETN 207 




PhenolHydroxylase_Tcutaneum      FPDI-RSPCAIHSAESGSIMIIPREN-----NLVRF-YVQLQARAEKG-GRV-------- 303 
A_niger999                       FPDI-RRRCAIHSP-AGSVMVIPRERIVTGEYLTRL-YVQVPGMANPDSDIAVGATPVSE 302 
A_niger687                       FPDI-RQSCAIHAGDRGSIMTAPREN-----RLVRF-YIYPKGDGRLSVEGK-------- 263 
A_niger951                       FPDI-RWPSSIDSP-HGHLLVITREG-----NTVRF-YVPLQEEDEIT-PSF-------- 270 
A_niger422                       FPDI-RKKSSIRSK-AGNILVIPREGDS--YNLTRF-YIELPTGT--------------- 249 
A_niger146                       FPDY-RRRCAIRTP-DGGCMLIPRKD-----EGLRI-FLQVDEKSQEHLDEN-GA---SG 262 
A_niger300                       FPDI-ETKCTIHSD-AGSIMVIPRED-----NMVRL-YVQIASSDDPDFD---------- 255 
A_niger617                       MPEADIGFASIESKSHGNVLWVQLDH-----GVKRIGFAMTPEMLAR------------- 251 
A_niger718                       MPIN-RAYGAIETTTHGNVLWAPLDH-----GATRIGYAYTPEIAAK------------- 248 
                                 :*       :* :   *  :    .         *: :                       
 
PhenolHydroxylase_Tcutaneum      ------DRTKFT-PEVVIANAKKIFHPYTFDV---QQLDWFTAYHIGQRVTEKFS-KD-- 350 
A_niger999                       LDDARARRQKVT-KEGILKQASDAFKPYYLRPKSDESIDWWAAYQIGQRVSPEFTVKDSA 361 
A_niger687                       ------DRSEVS-LDEIVGAMAKVMKPYTLTY---KHCDWWSIYKIGQRLVETYR-PH-- 310 
A_niger951                       ------DRSAVT-LDMLCERVKSIMSPFYFDF---KVCHWWAAYQVGRRLAPAVN--K-- 316 
A_niger422                       ------KAKDVR-LEDLQNAAKQIFSPYQIDF---VETVWWSAYAIGQRHADFFH-KD-- 296 
A_niger146                       QD-ALTGNSAFKLTQTVQSHINKVIHPYKMNI---TDIVWISQYRVAQRVVHHFSDPT-- 316 
A_niger300                       -------PRKTATAEDVQATARKILQPYWVEW---DRVEWYSVYPIGQGISEKYT-LD-- 302 
A_niger617                       ------YGDKLT-LEDAKVEAVKSMEPFSLEF---ETIDWWTLYGINQRVAECFYN-N-- 298 
A_niger718                       ------YPEGVT-EEVAVNEAIACLRPFNLKF---KEVHWWTLYKIGQRMARTFATHN-- 296 
                                               :         : *: .         * : * : :             
 
PhenolHydroxylase_Tcutaneum      --ERVFIAGDACHTHSPKAGQGMNTSMMDTYNLGWKLGLVLTGRAKR--------DILKT 400 
A_niger999                       GVPRVFIVGDACHTHSPKAGQGMNVSMMDSYNLAWKLAYHIHGLSPASAEPGQLHPLLDT 421 
A_niger687                       --DRIFLAGDAAHTHSPKAGQGLNVSMQDTYNLTWKLCSVITGEASP--------SILDT 360 
A_niger951                       --GRMYLVGDAVHTHSPKIGLGMNMSIQDGFNLGWKLALAVKEMASP--------SILDT 366 
A_niger422                       --YRVFLAGDACHTHSPKAGQGMNVSLQDGYNMGWKLASVLKGLAHP--------SLLET 346 
A_niger146                       --KRVFLLGDACHTHSPKAGQGMNVSISDAYNLTWKLALVMKGVAKA--------SLLET 366 
A_niger300                       --ERVFMGGDACHTHSPKAGQGMNTAFHDALNMAWKLHAVESGLAKR--------SILST 352 
A_niger617                       --DCVLLAGDACHTHSSGTAQGMNTGVHDAVNLAWKLGGIVKGWYND--------DVLRS 348 
A_niger718                       --NRVFICGDAAHTHSSGAAQGLNTGIHDAVNLAWKLALEVHGLSHP--------EVLNT 346 
                                     : : *** ****   . *:* .. *  *: ***                   :* : 
 
PhenolHydroxylase_Tcutaneum      YEEERHAFAQALIDFDHQFSRLFSGRPAKDVADEM--------GVSMDVFKEAFVKGNEF 452 
A_niger999                       YHLERHANAQQLIDFDRKFSTIFSGQLDTEE-----------SGMSHAEFVATFNTGNGF 470 
A_niger687                       YELERRPVGEELLKLDTELVQAYEQDTSVTE------------G--VERVR---GQYIDF 403 
A_niger951                       YKSERHQLAKMLLEFDQKWAAFFLKQKKKQQQLGL-EAPPEANPEDIQAMQDVFSENELF 425 
A_niger422                       YVLEREKVAIDLINFDRYFAKLFSSQGSAT----------------PKEFQEGFIKSGKY 390 
A_niger146                       YEQERLWVAQQLIEFDALFARQFGQKDKLD----------------SQNLRETWEMGHGF 410 
A_niger300                       YETERKDIAETLLSFDNKYAALFSKRRPTAGEVGEASHTTAAAGGEEDEFVKTFKSSCEF 412 
A_niger617                       YDTERRPVAQHLIDLDKDFSATISGTVPDRYKD-L-------SLSSNELFAKVFDDTIDF 400 
A_niger718                       YTTERQSAVQRLLNYDRDISLLMTHKWPVWYDGDR-------SADLNVLLGEIFQDAAQF 399 
                                 *  **      *:. *                                 .         : 
 
PhenolHydroxylase_Tcutaneum      ASGTAINYDENLVTDKK---SSK------QELAKNCVVGTRFKSQPVVRHSEGLWMHFGD 503 
A_niger999                       TSGCGVEYGESMIVDRTASDGQDGPIRGTDYLSGILRPGRRLLNVKLRRHADGWHRDIQD 530 
A_niger687                       MTGVGVTYGPNQLVAGK---KAD------TAVANNIKIGMRLSSHPVVGQADGISMQLSS 454 
A_niger951                       AEGHVSFYKASPIVHK-----GS------TTVARHLTAGERFPVALIRKQADGQPWWTSR 474 
A_niger422                       TAGLTAKYDESPITSDT---GVS------NELAKNVVVGMRLPSAQVVRFCDSKPLQLAA 441 
A_niger146                       TSGCGYEYPANLLVNPDVRTSIN------NQAVEPLTPGKRLLPIDLIRHIDGNHVRMLD 464 
A_niger300                       TSGYGVAYKPNVFTWDATHPAQSPL---FDVPGVRLTPGRAFTPTTVTRLADSNHVHLEQ 469 
A_niger617                       CIGLGIHYNESTINKT--------------SLTTAISAGWRAPDALVYAPGSRLPVRLFH 446 
A_niger718                       NTGLGISYEANVINQPL---EP------STEVAVGVQPGSRAPDTELTMPGTFQSVRMHQ 450 
                                   *    *  . .                         *       :              
 
PhenolHydroxylase_Tcutaneum      RLVTDGRFRIIVFAGKATDATQMSRIKKFSAYLDSENSVISLYTPKV------------- 550 
A_niger999                       DLASTGRFRVLTLTSDDLLNAQSASA----------RSLQDVSALLG------------- 567 
A_niger687                       RLTSNGAWRLLVFPGDLREPRNQSRLSRFTNQFNEQPHLPCLHKDQS------------- 501 
A_niger951                       LLKSDGRFRILLLVGDCRLEDQKSRILALNNGLLE---LQKRFTPPK------------- 518 
A_niger422                       SLKSDCRWRVIAFSGDLTVSQNMAALQAIGGYLGSDDSPLQRFRLRS------------- 488 
A_niger146                       IMPSNGRFHLFIFAGNDLSS---PTLQKLGNTLDSPHSPMSLFNLLPLELMERFRHEDIT 521 
A_niger300                       EIPANGAFRIFIFAGKQDKTS--KAITDLAANLEKERSFLSVYRRADIADVSFFEN---- 523 
A_niger617                       LMPNVGAWSILLLAGH-PEKTRQSLI-RAVEMVKQLSES--------------------- 483 
A_niger718                       VLRNRCQFLAVVFTGGDIETAKLDLL-PLREYLDSHPEL--------------------- 488 
                                  :     :  . : .                                              
 
PhenolHydroxylase_Tcutaneum      ------SDRNSRIDVITIHSCHRDDIEMHDFPAPA----LHP-KWQYDFIYADCDSW--H 597 
A_niger999                       ------TFPAGVIEQIVVHPQLPNDFEWDNLPACVKEHAEMR-------FY--------N 606 
A_niger687                       ------NRCSPLLETIVVHSSPRTSVNLLDLPEIFHPFDETW-GWDYSRVFADDGSY--G 552 
A_niger951                       ------QKLDSVIEVKAVHSAPVDDVELSDFPPILRQFDDTT-GWDYTKVWSDSECF-WD 570 
A_niger422                       ------GEPDSLIEPILVAHGERHGFELEQIPQSFYPFTGKNHIRDLHKIFFDDESY--N 540 
A_niger146                       TASVPFTNKAYVLDLFLIHSQNHLDVQLGNIPSPFS---TK---WPMN-VYSD------- 567 
A_niger300                       --H---LPHSKLFSICLVYAGEKNQIDVDSIPKILRDYHHHL--------YADNIPDVRV 570 
A_niger617                       ------LPREMIRSLTVVAQSPAGGDQRFSIPTIGR-------------LYYD------- 517 
A_niger718                       ------STHPAIAWLTVCGSAGCSPYEVLGMTGFGD-------------TYFD------- 522 








PhenolHydroxylase_Tcutaneum      H-PHPKSYQAWGVDETKGAVVVVRPDGYTSLVTDLE----GTAEIDRYFSGILVEPK-EK 651 
A_niger999                       GSELEDAYGIYGVDPHQGAMVVVRPDGYVGIVVALG----EVDRVGEYLRRCIRTK---- 658 
A_niger687                       E-ACGQAYERYGIRDETGCLVLCRPDQHVAWLGSLV----EVEALDQYFGQFVPGS---- 603 
A_niger951                       EQCKGNAYEIWGVDRSRGAMVALRPDQYIGWIGELD----DVAGVTTYFEGFLREPR-PE 625 
A_niger422                       R-GHGHLYEHLGISPDKGAIVIVRPDQYVSAVFSLD----EYRRIGQFFEGFMIPQERPE 595 
A_niger146                       --FDGAAQNQLGVPEDSGALVVVRPDGYIGLVTGLD----NVEDVTSYFDGFMHRRI--- 618 
A_niger300                       PQATYAAHEKLGFDVEKGGVVVTRPDSHVACTIQLSEGSGTVDALNAFFGSFATKPLGQD 630 
A_niger617                       --PEGSAHAAYTVSDSNGAVVVVRPDGILGYATQLD----EASNVIKYFAGFITR----- 566 
A_niger718                       --ARGIAHIAYKLEPRKGRLVVIRPDGLIAFTCTLD----GEAIRQHFFRILKSQPEKTC 576 
                                             .    * :*  ***   .    *            ::            
 
PhenolHydroxylase_Tcutaneum      SGAQTEADWTKSTA 665 
A_niger999                       -------------- 658 
A_niger687                       -------------- 603 
A_niger951                       AVL----------- 628 
A_niger422                       SLTGSKL------- 602 
A_niger146                       -------------- 618 
A_niger300                       SQ-QSRL------- 636 
A_niger617                       -------------- 566 
A_niger718                       S------------- 577 
 
Figure 3.29:  A. niger target phenol hydroxylase alignments.  Alignments were generated using 
ClustalOmega
72
 where  an asterix (*) represents conserved, a colon (:) strongly conserved, and  a 
period (.) weakly conserved residues.  T. cutaneum phenol hydroxylase has been included as a 
reference sequence where its two known catalytic residues have been highlighted in gray
76
.  In 
addition, Rossman fold fingerprint regions have been indicated in yellow.  
3.5.1.2 Comparison of aromatic ring decarboxylases  
 The sequence alignment in Fig 3.30 aligns the sequence of the A. niger 2,3-
dihydroxybenzoate decarboxylase with several other characterized aromatic ring decarboxylases 
from other organisms (both bacterial and fungal).  The alignments reveal that the A. niger 
sequence contains three of the four proposed metal binding residues
39
, consisting of Glu8, 
His164, and Asp287 while the fourth residue, His10, is not conserved.  These four proposed 
metal binding residues are highlighted in gray (Fig 3.30).   
2,3_DHB_decarboxylase_A_niger                MLGKIALEEAFALPRFEEKTRWWASLFSVD--PETHVKEITDINKLRIEHADKYGVGYQI 58 
2,6_DHB_decarboxylase_Rhizobium              MQGKVALEEHFAIPETLQDSA----GFVPGDYWKELQHRLLDIQDTRLKLMDAHGIETMI 56 
Salicylate_decarboxylase_T_monoliiforme      MRGKVSLEEAFELPKFAAQTKEKAELYIAPNNRDRYFEEILNPCGNRLELSNKHGIGYTI 60 
2,3_DHB_decarboxylase_A_oryzae               MLGKIALEEAFALPRFEEKTRWWASLFSTD--AETHVKEITDINKIRIEHADKHGVGYQI 58 
DHB_decarboxylase_Polarmonas_sp              MNGKIALEEHFATEETLMDSA----GFVPDKDWPELRSRLLDIQDRRVRLMDEHGIETMI 56 
                                             * **::*** *   .   .:      :           .: :    *:.  : :*:   * 
 
2,3_DHB_decarboxylase_A_niger                LSYTAPGVQDIWDPVEAQALAVEINDYIAEQIRDKPDRFGAFATLSMHNPQEAASELRRC 118 
2,6_DHB_decarboxylase_Rhizobium              LSLNAPAVQAIPDRRKAIEIARRANDVLAEECAKRPDRFLAFAALPLQDPDAATEELQRC 116 
Salicylate_decarboxylase_T_monoliiforme      YSIYSPGPQGWTERAECEEYARECNDYISGEIANHKDRMGAFAALSMHDPKQASEELTRC 120 
2,3_DHB_decarboxylase_A_oryzae               LSYTAPGVQDIWDPVEAQALAVEINDYIAEQVRVNPDRFGAFATLSMHNPKEAADELRRC 118 
DHB_decarboxylase_Polarmonas_sp              LSLNAPAVQAIADSTRANETARRANDFLAEQVAKQPTRFRGFAALPMQDPELAARELERC 116 
                                              *  :*. *   :  ..   * . ** :: :   .  *: .**:* :::*. *: ** ** 
 
2,3_DHB_decarboxylase_A_niger                VQTYGFKGALVNDTQRAGPDGDDMIFYDNASWDIFWQTCTELDVPLYLHPRNPTGTIYEK 178 
2,6_DHB_decarboxylase_Rhizobium              VNDLGFVGALVNGFSQEG-DGQTPLYYDLPQYRPFWGEVEKLDVPFYLHPRNPLPQD-SR 174 
Salicylate_decarboxylase_T_monoliiforme      VKELGFLGALVNDVQHAGPEGETHIFYDQPEWDIFWQTCVDLDVPFYLHPEPPFGSYLRN 180 
2,3_DHB_decarboxylase_A_oryzae               VEKYGFKGALVNDTQRAGPDGDDMIFYDNADWDIFWQTCTELDVPFYMHPRNPTGTIYEK 178 
DHB_decarboxylase_Polarmonas_sp              VKELGFVGALVNGFSQDN-RSAVPLYYDMAQYWPFWETVQALDVPFYLHPRNPLPSD-AR 174 
                                             *:  ** *****. .: .  .   ::**  .:  **     ****:*:**. *      . 
 
2,3_DHB_decarboxylase_A_niger                LWADRKWLVGPPLSFAQGVSLHVLGMVTNGVFDRHPNLQLIMGHLGEHVPFDMWRINHWF 238 
2,6_DHB_decarboxylase_Rhizobium              IYDGHPWLLGPTWAFAQETAVHALRLMASGLFDEHPRLNIILGHMGEGLPYMMWRIDHRN 234 
Salicylate_decarboxylase_T_monoliiforme      QYEGRKYLIGPPVSFANGVSLHVLGMIVNGVFDRFPKLKVILGHLGEHIPGDFWRIEHWF 240 
2,3_DHB_decarboxylase_A_oryzae               LWADRKWLVGPPLSFAHGVSLHVLGMVTNGVFDRHPKLQIIMGHLGEHVPFDMWRINHWF 238 
DHB_decarboxylase_Polarmonas_sp              IYDGHAWLLGPTWAFGQETAVHALRLMGSGLFDKYPALKIILGHMGEGLPYSMWRIDHRN 234 
83 
 
                                              : .: :*:**  :*.: .::*.* :: .*:**..* *::*:**:** :*  :***:*   
 
2,3_DHB_decarboxylase_A_niger                EDRKKLLGLAE---TCKKTIREYFAQNIWITTSGHFSTTTLNFCMAEVGVDRILFSIDYP 295 
2,6_DHB_decarboxylase_Rhizobium              AWVKL-----PPRYPAKRRFMDYFNENFHITTSGNFRTQTLIDAILEIGADRILFSTDWP 289 
Salicylate_decarboxylase_T_monoliiforme      EHCSRPLAKSRGDVFAEKPLLHYFRNNIWLTTSGNFSTETLKFCVEHVGAERILFSVDSP 300 
2,3_DHB_decarboxylase_A_oryzae               EDRKKLLGLAE---TCKKTIRDYFAENIWITTSGHFSTTTLNFCMAEVGSDRILFSIDYP 295 
DHB_decarboxylase_Polarmonas_sp              AWIKT-----TPKYPAKRKIVDYFNENFYLTTSGNFRTQTLIDAILEIGADRILFSTDWP 289 
                                                .           .:: : .** :*: :****:* * **  .: .:* :***** * * 
 
2,3_DHB_decarboxylase_A_niger                FETFEDACVWFDGAELNLS-------DKAKIGRDNAARLFKLGAFRDYDAKVKA------ 342 
2,6_DHB_decarboxylase_Rhizobium              FENIDHASDWFNATSIAEA-------DRVKIGRTNARRLFKLDGA--------------- 327 
Salicylate_decarboxylase_T_monoliiforme      YEHIDVGCGWYDDNAKAIMEAVGGEKAYKDIGRDNAKKLFKLGKFYDSEA---------- 350 
2,3_DHB_decarboxylase_A_oryzae               FETFSDACEWFDNAELNGT-------DRLKIGRENAKKLFKLDSYKDSSA---------- 338 
DHB_decarboxylase_Polarmonas_sp              FENIDHAADWFENTSISEA-------DRKKIGWGNAQNLFKLNRAENLYFQSHHHHHHWS 342 
                                             :* :. .. *::                 .**  ** .****.                  
 
2,3_DHB_decarboxylase_A_niger                ------ 342 
2,6_DHB_decarboxylase_Rhizobium              ------ 327 
Salicylate_decarboxylase_T_monoliiforme      ------ 350 
2,3_DHB_decarboxylase_A_oryzae               ------ 338 
DHB_decarboxylase_Polarmonas_sp              HPQFEK 348 
 
Figure 3.30: Alignment of A. niger 2,3-dihydroxybenzoate decarboxylase with selected 
characterized aromatic-ring decarboxylases.  Alignments were generated using ClustalOmega
72
 
where  an asterix (*) represents conserved, a colon (:) strongly conserved, and a period (.) 
weakly conserved residues.  A. niger 716 has been aligned against 2,6-dihydroxybenzoate 
decarboxylase from Rhizobium sp. Strain MT5-10005
39
,  salicylate decarboxylase from 
Trichosporon monoliiforme
41
, 2,3-dihydroxybenzoate decarboxylase from Aspergillus oryzae
38
, 
and dihydroxybenzoate decarboxylase from Polarmonas sp
40
.  Residues potentially involved in 
metal ion binding have been highlighted in gray. 
3.5.2 A. niger salicylate hydroxylase active site motifs 
 Salicylate hydroxylases have been proposed to have two domains involved in the 
salicylate hydroxylase active site consisting of AAH(A/S)(M/L)(L/V)PH(Q/H)G(Q/A)GA and 
AGV
82
.  The  A. niger putative salicylate hydroxylases described above, A. niger 577, 767, and 
534 have been modeled, and features at the predicted active sites have been aligned using 
PyMOL and are depicted in Figure 3.31.  This alignment shows there are no major differences in 




Figure 3.31: Alignment of the predicted active site structures of the A. niger putative salicylate 
hydroxylases.  Models were predicted using I-TASSER and the overlaid image was generated 
using PyMOL; A. niger 577 (red); A. niger 767 (orange); A. niger 534 (fuchsia); FAD (yellow); 
salicylate (blue).  Residues have been labelled according to A. niger 577. 
 
3.5.2.1 Accessibility of salicylate to salicylate hydroxylase active sites 
 Potential entrances for substrate (salicylate) to the hydroxylase active sites are shown in 
Figure 3.32.  Panel A, B, C, and D represent salicylate (blue) in the P. putida, A. niger 577, A. 
niger 767, and A. niger 534 active sites respectively.  In P. putida and A. niger 577 salicylate has 
easy access through an appropriately sized entrance to reach the active site while in the case of A. 
niger 767 and 534 the entrance seems to be much smaller and substrate may not be able to reach 




Figure 3.32: Potential substrate entrances to salicylate hydroxylase active sites.  Openings for 
substrate are shown for P. putida salicylate hydroxylase (A), A. niger 577 (B), A. niger 767 (C), 
and, A. niger 534 (D) in the presence of salicylate (blue) and FAD (yellow).  Enzyme models 
were produced using I-TASSER and visualized using PyMOL. 
3.5.2.2 Potential catalytic serine residues 
 Serine (S49) has been proposed as a catalytic residue involved in the deprotonation of the 
salicylate hydroxyl group in P. putida salicylate hydroxylase
28
.  This serine is located 3.11 Å 
away from the salicylate hydroxyl group shown in panel A.  It is also conserved in A. niger 577 




Figure 3.33: Potential catalytic serine residue in A. niger 577. Serine residues are indicated in 
red, with the distance between the nearest serine to the salicylate hydroxyl group measured in Å.  
FAD and salicylate are represented in yellow and blue respectively.  P. putida and A. niger 577 
are shown in panel A and B respectively where the A. niger 577 protein model was generated 
using I-TASSER and visualised using PyMOL. P. putida salicylate hydroxylase is a published 
structure (PDB ID: 5EVY). 
3.5.3 Bioinformatic evidence suggests a potential salicylate 5-hydroxylase in A. niger 
 Fig 3.34 shows the location of 2 genes in the NRRL3 Gbrowse app located directly next 
to each other
23
.  On the left is a putative gentisate 1,2-dioxygenase and on the right an aromatic-
ring hydroxylase-like protein.  NRRL3_10244 has been expressed in our lab (Alain Patrick 
Semana, personal communication) and shows gentisate 1,2-dioxygenase activity so 
NRRL3_10245 (A. niger 1188051) is possibly a salicylate 5-hydroxylase since genes coding for 







Figure 3.34: Screenshot of NRRL3_10244 and NRRL3_10245 (A. niger 1188051) in Gbrowse 
3.5.4 Phylogenetic analysis of A. niger target sequences 
 A phylogenetic tree was constructed using alignments of all the target putative salicylate 
and phenol hydroxylase sequences used in this study (Figure 3.35).  Additionally, a few known 
salicylate and phenol hydroxylase sequences from the literature were added, including 
Pseudomonas putida salicylate hydroxylase
80
, Epichloë festucae salicylate hydroxylase
33
, 
Pseudomonas alcaligenes 3-hydroxybenzoate 6-hydroxylase
84
, and Trichosporon cutaneum 
phenol hydroxylase
85
.  The phylogenetic tree shows two main clusters, one with the annotated 
salicylate hydroxylase sequences (top half) and the second with those annotated as phenol 
hydroxylases (bottom half).  However, with the addition of the sequences from the literature the 
tree reveals that the A. niger sequences belong in several different branches potentially relating 
to the differences in substrate specificity and other enzymatic properties.  Three main branches 
are observed.  One consists of sequences that resemble most closely salicylate hydroxylase or 3-
hydroxybenzoate 6-hydroxylase.  A second branch comprises two sequences (A. niger 999 and 
146) that are distinct from either salicylate hydroxylase or phenol hydroxylase. A third branch 
consisting of sequences most similar to T. cutaneum phenol hydroxylase.  Greater analysis of 
88 
 
these main branches and smaller branches within the main branches will be covered in the 
Discussion.  
 
Figure 3.35:  Phylogenetic tree of A. niger target and literature hydroxylase sequences.  
Sequences with an asterix (*) indicate the sequences of enzymes that were successfully 

















 Aromatic ring hydroxylases and other enzymes that prepare aromatic compounds for ring 
cleavage have been quite well characterized in bacteria, but much less work has been carried out 
in fungi.  With advances in DNA sequencing and increased fungal genome availability, many 
fungal genes have been annotated as coding for enzymes that may be involved in aromatic 
degradation.  However, most of these annotations are based on weak sequence conservation with 
bacterial counterparts.  One of the main goals of this project was to express predicted aromatic 
ring hydroxylases from the model fungus, Aspergillus niger, characterize them, and compare 
them with  their bacterial counterparts.  The experimental evidence thus obtained would allow a 
better understanding of fungal aromatic ring activating enzymes and the genes encoding them. 
 In addition to A. niger being fully sequenced and having a genome annotated with a large 
number of supposed aromatic ring-hydroxylase sequences, there are other reasons why it was 
chosen for this study.  A. niger is one of the most well-studied fungi, and it has been shown to 
grow on various aromatic compounds, including salicylate and benzoate, which can each be used 
as single carbon energy sources for growth.  A. niger also has many industrial applications. 
 During the course of this project five A. niger enzymes were successfully expressed, 
purified, and characterized.  These included three putative salicylate hydroxylases (A. niger 767, 
577, and 534), a putative phenol hydroxylase (A. niger 999), and a 2,3-dihydroxybenzoate 
decarboxylase (A. niger 716).  The 2,3-dihydroxybenzoate decarboxylase had been previously 
isolated from A. niger but was cloned and expressed in E. coli for this project.   
 Aromatic hydroxylase target sequences in the A. niger genome were chosen based on 
their annotations and Blasted against the Swissprot/ Uniprot database to search for similarity 
against already characterized enzymes.  Fourteen sequences were chosen (Table 3.1): most have 
a query cover >80 % and a sequence identity between 30-38 % with other published aromatic 
ring-hydroxylating enzyme sequences.  This may seem like a low sequence conservation for 
proteins that are predicted to carry out similar function, however, since these sequences come 
from different organisms, including prokaryotes, it may not be too surprising.  In addition, 
substrate specificity may differ, contributing to the low sequence similarity.   
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 Selected genes were amplified by PCR using A. niger cDNA and cloned into the 
pLATE11 vector using the LIC cloning method.  Of the 15 (14 aromatic-ring hydroxylases and 1 
2,3-dihydroxbenzoate decarboxylase) gene targets only 11 were successfully cloned.  A. niger 
687 was not amplified by PCR, and A. niger 422 was not amplified in sufficient quantity for 
cloning.  This may have been due to low cDNA levels of these target genes in the A. niger 
template DNA.  The cDNA used was extracted from A. niger grown on alfalfa and barely, plant 
material that contains lignin, and aromatic secondary metabolites that could up-regulate 
expression of aromatic degrading enzymes.  A. niger 146 and 951 were cloned but DNA 
sequencing revealed they contained introns (Fig 3.15 and 3.16) suggesting that they were 
probably amplified by contaminating genomic DNA (gDNA).   
 Of these eleven successfully-cloned genes, only five were expressed in soluble form in E. 
coli BL21(DE3), and were active.  These include: the putative salicylate hydroxylases, A. niger 
577, 767, and 534 (Fig 3.4); the putative phenol hydroxylase A. niger 999 (Fig 3.17); and A. 
niger 2,3-dihydroxybenzoate decarboxylase (A. niger 716) (Fig 3.25).  In the case of A. niger 
999, Rosetta (DE3) was used instead of E. coli BL21 (DE3) for expression since greater 
expression levels were detected in Rosetta (Fig 3.17).  Rosetta (DE3) is an E. coli variant which 
contains an additional chloramphenicol-resistant plasmid which provides tRNA genes for codons 
which are rarely used in E. coli
86
.  For the other target genes, A. niger 655 and 617 were 
expressed but insoluble, while no expression was observed for A. niger 860, 300, and 718.  
Additionally, A. niger 684 was soluble and inactive.  Using Rosetta (DE3) and Shuffle E. coli 
strains instead of BL21 (DE3) for these targets did not improve the expression.  
 Once the putative hydroxylases were expressed, enzyme activities in the presence of 
salicylate/phenol and NAD(P)H were measured in the crude extracts using the assays described 
in the Materials and Methods.  For all four enzymes, activity was observed in crude extracts, but 
increased (150-500 %) in the presence of FAD (data not shown).  Therefore, FAD was 
supplemented in at least 2-fold excess (200 µM - 800 µM FAD) in all 4 enzyme crude extracts to 
ensure that all the enzymes had FAD cofactor bound prior to purification. 
 The 5 protein purifications were carried out with various degrees of success.  In general 
the putative salicylate hydroxylases, A. niger 767, 577, and 534, were quite well purified, with 
between 3 and 4 fold increases in purity (Fig 3.5, 3.6, and 3.7).  On the other hand, the putative 
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phenol hydroxylase, A. niger 999, and the 2,3-dihydroxybenzoate decarboxylase, A. niger 716, 
showed minimal increases in specific activity during purification, although the polyacrylamide 
gels summarizing the purification steps showed that some contaminants were removed (Fig 3.18 
and 3.26).   
 By UV-VIS spectroscopy the three putative salicylate hydroxylases (A. niger 577, 767, 
and 534) were confirmed to contain flavin based on the two characteristic flavin peaks at 375 and 
450 nm.  In all three cases there was little change in the absorbance of the bound and free flavin 
(Fig 3.8).  This bound flavin was identified as FAD by TLC (Fig 3.9).  A. niger 767, 577, and 
534 had FAD/protein ratios of 1.05, 1.04, and 1.10 respectively indicative of a single bound 
FAD.  Most reported salicylate hydroxylases including Pseudomonas putida
87
 salicylate 
hydroxylase, and the only other characterized fungal salicylate hydroxylase, isolated from 
Trichosporon cutaneum
88
, were also reported to contain one single FAD/polypeptide.  
 In addition to FAD, aromatic-ring hydroxylases require NADH or NADPH as electron 
donors to reduce the FAD prior to reaction with oxygen.  Many aromatic ring hydroxylases show 
preference for either NADH or NADPH.  Like most other salicylate hydroxylases
87,88
 reported in 
the literature, the putative salicylate hydroxylases expressed in this project appear to have a 
preference for NADH over NADPH (Table 3.10).   
 Previously-purified salicylate hydroxylases have been reported to be monomers in some 
organisms and dimers in others.  For example, the P. putida PpG7 (bacterial) salicylate 
hydroxylase is a monomer
11
, while the T. cutaneum (eukaryotic) salicylate hydroxylase has been 
reported to be a dimeric protein consisting of two non-identical subunits of 39.6 kDa and 38.2 
kDa, giving it an apparent molecular weight of 77.8 kDa
88
.  The oligomeric states of the three 
putative A. niger salicylate hydroxylases were investigated.  A. niger 577 and 534 were found to 
be dimers, while A.niger 767 behaved like a monomer.  The dimeric enzymes are likely 
homodimers since only one gene was expressed to produce each protein, although post-
translational modification has not been ruled out.    
 Substrate specificities of the three putative salicylate hydroxylases were examined by 
measuring NADH consumption rates, coupling of oxygen consumption to product formation, 
and product detection (Table 3.11, 3.12, and 3.13).  On the basis of these studies A. niger 577 is 
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the only enzyme of the three that appears to be a "true" salicylate hydroxylase.  It is very active 
with salicylate as a substrate, and oxygen consumption is tightly coupled to product formation 
with only 4.7 % diverted to H2O2 formation (Table 3.12).  Additional tightly-coupled (<15% 
H2O2 formed) aromatic substrates were 4- or 5- methylsalicylate, and 2,3-, 2,5-, or 2,6-
dihydroxybenzoate (Table 3.12).  Hydroxylated products were detected for salicylate, 4-
methylsalicylate, and 5-methylsalicylate, yielding catechol, 4-methylcatechol, and 4-
methylcatchol (Table 3.13 and Fig 3.11). 
 The substrate specificity of A. niger 577 resembles that of other salicylate hydroxylases 
reported in the literature.  T. cutaneum salicylate hydroxylase  is also active on salicylate, 2,3-
dihydroxybenzoate, and 2,6-dihydroxybenzoate, resulting in formation of catechol for salicylate 
and pyrogallol for the two dihydroxybenzoates
17,88
.  However, the coupling of oxygen activation 
for these substrates by the T. cutaneum enzyme were not reported.  For the bacterial salicylate 
hydroxylase isolated by White-Stevens et al
29
 virtually no oxygen uncoupling was observed with 
salicylate as a substrate (as observed with A. niger 577).  Similarly, the specific activity of A. 
niger 577 and oxygen uncoupling did not vary much with 2,3-, 2,4-,and 2,5-dihydroxybenzoates 
compared to the bacterial enzyme.  However, the oxygen uncoupling with A. niger 577 was 
much lower than the enzyme isolated by White-Stevens et al
29
 with 2,6- dihydroxybenzoate (1% 
H2O2 formation compared to 28 % H2O2 formation).  Other substrates could not be compared 
since no data have been reported.   
 According to the data compiled on BRENDA for salicylate 1-hydroxylase (EC 
1.14.13.1), salicylate hydroxylase specific activity ranges from as low as 0.58 µmol/min/mg  to 
as high as 37 µmol/min/mg
89
.  Most of these data are for bacterial salicylate hydroxylases but for 
the two other known fungal salicylate hydroxylases, from T. cutaneum and Epichloë festucae the 
specific activities are, respectively 37 µmol/min/mg
88
 and 0.71 µmol/min/mg
33
.  The specific 
activity of A. niger 577 is 31.69 µmol/min/mg, comparable to that of the T. cutaneum enzyme. 
 A. niger 767 is, on the other hand, a much poorer salicylate hydroxylase than A. niger 
577, having much lower activity with salicylate (7.68 µmol/min/mg) and with 85 % of oxygen 
consumed diverted to H2O2
 
(Table 3.11 and 3.12).  In fact, this enzyme exhibited oxygen 
uncoupling between 85-100% with nearly all the substrates tested, with the exception of 4-
methoxysalicylate (Table 3.12).  With 4-methoxysalicylate, oxygen uncoupling was significantly 
93 
 
lower (only 43.7% diversion to H2O2) and the specific activity (11.4 µmol/min/mg) was higher 
than that observed with salicylate (7.68 µmol/min/mg).  Furthermore, the binding of 4-
methoxysalicylate to A. niger 767 is about 4-fold tighter than with salicylate, consistent with the 
assay data that suggested 4-methoxysalicylate is a better substrate for A. niger 767 than 
salicylate.  Unfortunately the product formed was never identified.   A. niger 767 showed the 
highest NADH consumption rate with 6-methylsalicyate, however this was accompanied by a 
high degree of oxygen uncoupling, with no 3-methylcatechol formation.  It is interesting to note 
that A. niger has been shown to express a 6-methylsalicylate synthase,  but no catabolic enzyme 
has yet been identified to break down 6-methylsalicylate
90
.     
 A. niger 534 was shown to be an NADH-dependent flavin-containing hydroxylase, but 
the aromatic substrate has not been identified: nearly all the oxygen was diverted to H2O2 with 
all substrates tested (Table 3.12).  Even with substrates where oxygen consumption was not 
completely uncoupled, no products were detected.  With salicylate, this enzyme had an NADH 
consumption rate of only 0.4 µmol/min/mg and an oxygen uncoupling of 98.6 % with no 
catechol formation.  The aromatic substrates tested act as non-substrate effectors that convert the 




 The similarities between the three hydroxylase sequences are quite low.  Using A. niger 
577 as the reference sequence, A. niger 767 and 534 display sequence identity of only 39 % (59 
% positives) and 33 % (53 % positives), respectively.  However, functionally important residues 
are mostly conserved in the FAD fingerprints, active site, substrate binding and NADH binding 
site regions (Fig 3.28).  The salicylate hydroxylase substrate active site is proposed to consist of 
2 highly conserved sequence motifs.  These include the 13 residue motif, 
AAH(A/S)(M/L)(L/V)PH(Q/H)G(Q/A)GA, which is located near the C-terminal end, and the 
short residue AGV sequence located near the N-terminal end of the protein
82
.  The first region 
also partly overlaps with FAD fingerprint 2 (Fig 3.28).  These conserved regions were 





 residues consisting of M/L and L/V are rarely conserved, which may be a general 
occurrence in fungi.   
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  In the first conserved motif, A. niger 577 and 767 have 11 out of 13 residues conserved 
(the 5th and 6th residues not conserved), while A. niger 534 has only 8 out of 13 residues 
conserved.   The three residues that differ in A. niger 534 from the other two sequences are a 
serine substituted for alanine (residue # 1), a glycine for alanine or serine (residue # 4), and an 
alanine instead of a glycine (residue # 10).     The second motif (AGV) was conserved in A. niger 
577 while in A. niger 767 and 534 the sequence is AGI.  Protein models were generated for all 3 
enzymes using the I-TASSER
70
 modelling server and visualized in PYMOL: the protein folds in 
these two regions are very similar (Fig 3.31).   
 Upon further inspection of the enzyme models, it is apparent that in A. niger 767 and 534 
there is a much smaller opening to the active site compared with that of A. niger 577 and the 
5EVY salicylate hydroxylase crystal structure the models were based on (Fig 3.32).  This may 
affect substrate access to the active site and therefore be a factor in substrate specificity.   
 Recently, with the publication of the first salicylate hydroxylase crystal structure, from 
Pseudomonas putida (PDB ID: 5EVY), a serine residue has been proposed to be involved in 
salicylate hydroxylase catalysis.  In the P. putida enzyme this is S49, which deprotonates the 
hydroxyl group of salicylate located only 3.11 Å away.
28
  It is interesting to note that in the three 
A. niger proteins studied here, this residue is only conserved in A. niger 577, the "true" salicylate 
hydroxylase (3.48 Å away) (Fig 3.33).  Therefore this residue could be important in determining 
optimal activity on salicylate.   
 However, E. festucae salicylate hydroxylase does not possess the catalytic serine found in 
A. niger 577 and P. putida salicylate hydroxylases.  This enzyme still catalyzes the conversion of 
salicylate to catechol albeit at a much lower rate of 0.71 µmol/min/mg compared to 31.69 
µmol/min/mg for A. niger 577.  It would be interesting to know the oxygen uncoupling of the E. 
festucae salicylate hydroxylase (thus far unreported) since it is possible that the serine residue 
may play a role in the extent of coupling.   
 A number of other putative A. niger salicylate hydroxylase target sequences weren't 
successfully expressed.  These sequences are included in a phylogenetic tree including model 
salicylate hydroxylases sequences from E. festucae and P. putida, and the expressed A. niger 
enzymes.  Unfortunately the sequence for T. cutaneum salicylate hydroxylase is unavailable.  
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The phylogenetic tree (Fig 3.35) shows that A. niger 577 is most similar to the E. festucae 
salicylate hydroxylase, the only previously-characterized fungal salicylate hydroxylase sequence 
in this tree.  Of the other two putative salicylate hydroxylases, A. niger 767 is the closest 
sequence to A. niger 577 while A. niger 534 is more distant:  the two latter sequences seem to 
specify enzymes that cannot function as efficient salicylate hydroxylases.    A. niger 684 appears 
to be more closely related to a 3-hydroxybenzoate 6-hydroxylase from P. alcaligenes than to any 
salicylate hydroxylases.  However, crude extracts of E. coli cells that expressed this enzyme did 
not show any activity on 3-hydroxybenzoate or salicylate even with the addition of FAD (data 
not shown).    Additionally, the insoluble protein A. niger 655 is the next most similar target to A. 
niger 577 and is thus potentially a salicylate hydroxylase as well.  Another unexpressed enzyme, 
A. niger 860, is unlikely to be a salicylate hydroxylase since it is more similar to A. niger 767 
than A. niger 577 
 The only successfully expressed and purified putative phenol hydroxylase in this study 
was A. niger 999.  The most extensively studied fungal phenol hydroxylase is that from 
Trichosporon cutaneum, originally isolated by Neujahr et al (1973)
35
.  In addition, a few other 
eukaryotic fungal enzymes capable of hydroxylating phenol to catechol are hydroquinone 
hydroxylase isolated from Candida parapsilosis CBS604
15
 and resorcinol hydroxylase from 
Gloeophyllum trabeum (Zhuoxuan Yang, MSc Thesis, Concordia University
91
.)  Unlike these 
eukaryotic enzymes, which are comprised of a single polypeptide, most bacterial phenol 
hydroxylases are multicomponent
13
. The results obtained with A. niger 999 therefore will be 
compared with these three fungal enzymes.   
 A. niger 999 contains FAD, which was identified by TLC (Fig 3.20).    The FAD 
absorbance peak was found at 443 nm, with a shoulder at 462 nm, comparable spectral features 




 and resorcinol 
hydroxylase
91
.  A. niger 999 was also determined to be associated with 1 FAD per polypeptide, 
which was also reported for T. cutaneum phenol hydroxylase
35
. 
 Single-component phenol hydroxylases such as these are usually reported to be dimers: 
they have a thioredoxin-like fold domain occurring at the C-terminal end of the protein which is 
involved in dimerization
76
.  A. niger 999 was also found to be a dimer, as size exclusion 
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chromatography indicated a molecular weight of 132.9 kDa (with an expected monomeric 
weight of 73.2 kDa.) 
 Different types of aromatic ring-hydroxylating enzymes seem to vary in their specificity 
for NADH vs. NADPH.  Salicylate hydroxylase type enzymes usually prefer NADH while 
phenol hydroxylases such as the T. cutaneum enzyme usually prefer NADPH
35
.  A. niger 999 
also prefers NADPH, with a rate nearly 6-fold faster observed with NADPH compared to NADH 
(Table 3.17).      
 A. niger 999 was active on a variety of aromatic substrates with the greatest activities 
observed with phenol (3.54 µmol/min/mg), p-cresol (3.11 µmol/min/mg), resorcinol (3.38 
µmol/min/mg), and hydroquinone (4.18 µmol/min/mg) (Table 3.18).  Amongst these substrates, 
the greatest oxygen uncoupling is observed with phenol, where 32 % of the oxygen consumed 
was diverted to H2O2, while the other three substrates exhibited uncoupling of about 5 % (Table 
3.19).  For all 4 of these substrates, product formation was detected using the catechol 2,3-
dioxygenase coupled assay.  The products formed for phenol, p-cresol, resorcinol, and 
hydroquinone appeared to be catechol, 4-methylcatechol, hydroxyquinol, and hydroxyquinol 
respectively (Fig 3.21).  
 These data indicate that this enzyme prefers p-cresol, resorcinol, and hydroquinone to 
phenol, but since the rates of NADPH consumption and oxygen uncoupling are so similar for all 
three substrates it is difficult to distinguish further between them on the basis of the data 
collected.  
 Comparison with the phenol hydroxylase from T. cutaneum reveals some significant 
differences.  T. cutaneum phenol hydroxylase has a specific activity of 8.3 µmol/min/mg
35
 with 
phenol as a substrate and an oxygen uncoupling of only 10 %
81
 compared to A. niger 999s' 
specific activity of 3.54 µmol/min/mg and 32 % oxygen uncoupling.  The T. cutaneum enzyme 
also has a broad substrate specificity but it exhibits much higher degrees of oxygen uncoupling 
with p-cresol and resorcinol than A. niger 999.  T. cutaneum phenol hydroxylase showed 40 % 
uncoupled oxygen with resorcinol as a substrate and 20 % with p-cresol, compared to about 5% 





 Compared to the resorcinol hydroxylase from Gloeophyllum trabeum which has a 
specific activity of 1.99 µmol/min/mg with phenol and 0.83 µmol/min/mg with resorcinol, A. 
niger 999 appears to be more active with specific activities of 3.54 µmol/min/mg (phenol) and 
3.38 µmol/min/mg (resorcinol).   The G. trabeum enzyme is nearly completely oxygen 
uncoupled with phenol and 25 % of the oxygen is diverted to hydrogen peroxide in the presence 
of resorcinol
91
.  Thus, A. niger 999 acts as a superior resorcinol hydroxylase since it displays 4 
fold higher activity and far less oxygen uncoupling (only 5 %). 
 Another characterized fungal aromatic-ring hydroxylase is hydroquinone hydroxylase 
isolated from Candida parapsilosis CBS604, which is highly active with many aromatic-ring 
substrates and shows virtually no oxygen uncoupling (unspecified by the authors).  This enzyme 
had a specific activity of 2.07 µmol/min/mg with phenol and 4.26 µmol/min/mg with 
hydroquinone
15
.  This is comparable with A. niger 999, for which specific activities were 3.54 
µmol/min/mg with phenol (32 % uncoupled) and 4.18 µmol/min/mg with hydroquinone (5 % 
uncoupled).  The exact proportion of oxygen uncoupled from hydroxylation is not reported for 
either phenol or hydroquinone for the C. parapsilosis enzyme and would be needed to fully 
compare the efficiency of hydroxylation between A. niger 999 and C. parapsilosis hydroquinone 
hydroxylase.   
 In summary, based on the data obtained, A. niger 999 is more effective at hydroxylating  
hydroquinone, p-cresol, and resorcinol than phenol, so having it annotated as a "phenol 
hydroxylase" is misleading.  
 In addition to A. niger 999, there were 7 other putative phenol hydroxylase genes from A. 
niger cloned for expression, without success in obtaining the corresponding enzymes.  However, 
their potential enzymatic activities are suggested by analysis of sequence alignments and a 
phylogenetic tree (Fig 3.29 and 3.35).  In this analysis, the inducible T. cutaneum "phenol 
hydroxylase" A. niger 999, was used as a reference sequence to identify which A. niger 
sequences are most likely to be phenol hydroxylases.  Sequence comparison shows that the 
protein characterized in this study, A. niger 999, is actually one of the more distantly related 
sequences to T. cutaneum phenol hydroxylase, with a sequence identity of only 34 % (48 % 
positives).  This low sequence identity, combined with its phylogenetic distance from the T. 
cutaneum enzyme (Fig 3.35) may account for the differing substrate specificity and catalytic 
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activities.  However, despite the low sequence identity, proposed catalytic residues Tyr 289 (Tyr 
279 in A. niger 999) and Asp 54 (Asp 86 in A. niger 999) are well conserved as are the sequences 
in the FAD and NADPH binding domains
76
.   
  A. niger 422, 951, and 687 are the sequences most likely to be phenol-specific 
hydroxylases since they share the same phylogenetic tree branch as  T. cutaneum phenol, 
hydroxylase, and possess both conserved catalytic residues highlighted in gray (Fig 3.29).  A. 
niger 146 shares the same branch as A. niger 999 but phenylalanine is substituted for tyrosine 
and serine is substituted for aspartate at the two catalytic positions, which would likely affect 
catalytic activity and/or specificity.  A. niger 617 and 718 are the most distantly related 
sequences on the phylogenetic tree and appear to be closer to salicylate hydroxylase than phenol 
hydroxylase (Fig 3.35). In fact, A. niger 617 is missing both catalytic residues (phenylalanine 
instead of tyrosine and threonine instead of aspartate) and A. niger 718 has isoleucine substituted 
for aspartate.   
 One additional target sequence was A. niger 300, which is distantly related to phenol 
hydroxylase, as well as salicylate hydroxylase (Fig 3.35).  This enzyme may be a different type 
of aromatic-ring hydroxylating enzyme.  Recent studies in A. nidulans have identified enzymes 
which are promisingly involved in the degradation pathway of salicylate and benzoate.  One of 
these is AN10952, which on the basis of proteomic studies, is believed to be a 4-
hydroxybenzoate 3-monooxygenase (an enzyme that converts 4-hydroxybenzoate to 
protocatechuate)
16
.  The sequence alignment between this enzyme and A. niger 300 is 82.6 % 
over a sequence coverage of 98.6 %, suggesting that A. niger 300 may be a 4-hydroxybenzoate 
3-monooxygenase.  This is the first sequence identified in this study that is potentially involved 
in the formation of protocatechuate, rather than catechol. 
 Apart from the aromatic-ring hydroxylase sequences already discussed there was one 
other target sequence, A. niger 1188051 (NRRL3_10245), which is annotated as an aromatic-
ring hydroxylating enzyme.  Its closest blast hit is 6-hydroxynicotinate 3-monooxygenase, but it 
could potentially be a salicylate 5-hydroxylase which converts salicylate into gentisate because 
the gene coding for this enzyme is directly next to an annotated gentisate 1,2-dioxygenase (Fig 
3.34).  In fact, Alain Patrick Semana in our laboratory has managed to express, and confirm that 
the enzyme encoded by this gene has gentisate 1,2-dioxygenase activity.  To date, salicylate 5-
99 
 
hydroxylase is an enzyme that has only been found in bacteria
12
.  Unfortunately, PCR 
amplification attempts of this enzyme's gene sequence have been unsuccessful under all 
conditions attempted.    
 Another enzyme involved in hydroxy-aromatic metabolism, A. niger 716, is an aromatic-
ring decarboxylase for 2,3-dihydroxybenzoate.  This enzyme had been previously isolated from 
A. niger and characterised
2,4
, but in this work it was expressed in E. coli and purified.  Like the 
salicylate and phenol hydroxylases already discussed it forms the same product, catechol.  
However, instead of hydroxylating the aromatic ring, the 2,3-dihydroxybenzoate decarboxylase 
removes the carboxyl group of 2,3-dihydroxybenzoate which is released as CO2.   
 This enzyme has been expressed and characterized from A. niger by two research groups 
in the past, firstly by Subba Rao et al (1967)
2
, and later by Kamath et al (1987)
4
. Most of the 
findings with the E. coli-produced enzyme are as those with the enzyme expressed by the native 
organism, although there are a few differences as well.  For one, the pH optimum was previously 
reported to be 5.2
2
, but in this study it was found to be 6.2 (Figure 3.27).  Another difference was 
that the enzyme appears to be a trimer with a molecular weight of 122.4 kDa and an expected 
monomeric weight of 39.2 kDa, instead of a tetramer as previously reported.  However, the 
shape of a protein also influences the gel filtration elution profile so additional confirmation of 
the oligomeric structure (for example using analytical ultracentrifugation) would be desirable.  
The closely related 2,3-dihydroxybenzoate decarboxylase from Aspergillus oryzae had an 
estimated molecular weight of 130 kDa (by gel filtration) for a 38.0 kDa monomer which would 
appear to be a trimer, but was shown to be a tetramer after correction using its S20,w value
38
.  The 
2,3-dihydroxybenzoate decarboxylase from T. cutaneum was shown to be a dimer
92
 and shares 
almost identical properties with the two Aspergillus enzymes.   
 One common element of aromatic ring decarboxylases is that they share a TIM-barrel 
motif which may be involved in binding of cofactors such as metal ions
93
.  However, even 
though all enzymes of this class are predicted to adopt this fold, activity has often been reported 
to be unaffected by metal ion addition to assays
39
.  This is the case for the eukaryotic aromatic 
ring-decarboxylases such as the 2,3-dihydroxybenzoate decarboxylases from A. oryzae
38
 and T. 
cutaneum
92
 as well as salicylate decarboxylase from Trichosporon moniliiforme
41
.  Previous 
studies have reported that A. niger 2,3-dihydroxybenzoate decarboxylase also appears not to 
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.  The data reported in this thesis confirm that A. niger 2,3-
dihydroxybenzoate decarboxylase activity is not increased by the addition of various metal ions  





present in the purified protein (Table 3.25)  After extensive dialysis in chelator-containing buffer  
it was observed that the activity was enhanced in the presence of Ca
2+
 (but not other metal ions) 
by nearly 60 % (Table 3.27).  This is the first evidence that the activity may be metal ion 
dependent.  However, the results of ICP-MS measurements for Ca
2+
 on the dialysis/chelator 
treated samples were inconclusive since the buffer control sample showed a higher calcium 
content than the protein sample. 
 Few crystal structures of aromatic ring decarboxylases have been solved but one of them 
is a 2,6-dihydroxybenzoate decarboxylase from Rhizobium sp. Strain MTP-10005 (PDB ID: 
2DVT)
39
.  The protein was crystallized in the presence of 2,6-dihydroxybenzoate (substrate) and 
Zn
2+
 (metal co-factor).  In this crystallographic study, potential metal binding residues have been 
identified; Glu8, His10, His164, and Asp287.  These four residues seem to be well conserved 
amongst bacterial aromatic-ring decarboxylases, however, in fungal sequences alanine is 
substituted for His10 (Fig 3.30).  It is possible that this would weaken metal binding to the 
enzyme. 
 Many of the reactions catalyzed by other aromatic ring decarboxylase enzymes are 
reversible and oxygen sensitive 
41
.  A. niger 2,3-dihydroxybenzoate decarboxylase was also 
shown to catalyze the reverse reaction, carboxylation of catechol to 2,3-dihydroxybenzoic acid 
(Table 3.23).  The presence of reducing agents such as DTT had no effect on the enzyme activity 
in either the forward or reverse reactions, indicating that this enzyme is oxygen insensitive 









 The goal of the work described in this thesis was to identify and characterize new 
enzymes from the fungus, Aspergillus niger, that are active on the aromatic-rings of simple 
benzene derivatives.  Although bacterial versions of these enzymes have been isolated and 
studied in great deal, very few fungal variants have been examined.  Nonetheless, large numbers 
of genes from fungal genomes have been annotated to be these enzymes via bioinformatic 
methods, with little to no experimental verification.  Aspergillus niger is one of these fungi, and 
since it has been shown to grow on various aromatic ring compounds, it was chosen as the source 
for a representative group of target genes. 
 Fifteen target genes were chosen for study.  However only a third of the selected enzyme 
targets were successfully cloned, expressed, and characterized.  These five characterized 
enzymes, along with additional bioinformatic analysis of the other ten targets, provide 
experimental insight into several types of enzymes A. niger has to degrade aromatic compounds.  
Three of these five characterized enzymes were shown to be a: salicylate hydroxylase (A. niger 
577); a hydroxylase with poor activity on salicylate (A. niger 767); and a hydroxylase enzyme 
similar to salicylate hydroxylases but with no identified aromatic substrate (A. niger 534).  The 
other two were: an aromatic-ring hydroxylase annotated as phenol hydroxylase which is more 
efficient at hydroxylating hydroquinone, p-cresol, and resorcinol than phenol (A. niger 999); and 
a 2,3-dihydroxybenzoate decarboxylase (A. niger 716).  In addition, bioinformatic studies 
suggest that A. niger may have genes encoding phenol hydroxylases, a 4-hydroxybenzoate 3-
monooxygenase, and a salicylate 5-hydroxylase. 
 One of the significant findings is that A. niger has three different enzymes capable of 
producing catechol from 3 different substrates.  Salicylate, phenol, and 2,3-dihydroxybenzoate 
are converted to catechol by A. niger 577, A. niger 999, and A. niger 716.  There are several 
microorganisms that can form catechol from one or two of these three starting compounds, but 
apart from T. cutaneum, no other organism (bacterial or fungal) appears to have been identified 
that can express enzymes to convert all three of these substrates to catechol
35,88,92
.  Also of note 
is that the salicylate hydroxylases and 2,3-dihydroxybenzoate decarboxylase from A. niger and 
T. cutaneum have similar activities and enzymatic characteristics.  A few putative phenol 
hydroxylases from A. niger (A. niger 687, 951, 422) that were not successfully expressed in this 
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study are likely to be similar to the well characterized T. cutaneum phenol hydroxylase
35
 based 
on phylogenetic analysis and sequence alignment.  A. niger 999, which was successfully 
expressed, acts as a phenol hydroxylase but with lower activity and more oxygen diverted to 
H2O2 than its T. cutaneum counterpart.  In contrast,  A. niger 999 seems to be able to process 
hydroquinone, p-cresol, and resorcinol than the known T. cutaneum enzymes.  
 A. niger has the potential to be a fungus capable of degrading a wider range of benzene 
derivative compounds then most, and in our lab enzymes capable of cleaving catechol, 
protocatechuate, hydroxyquinol, and gentisate have all been confirmed.  This thesis has 
identified enzymes capable of producing catechol and hydroxyquinol and has proposed the 
existence of enzymes capable of producing protocatechuate and gentisate, i.e. a 4-
hydroxybenzoate 3-monooxygenase (A. niger 300), and a salicylate 5-hydroxylase (A. niger 051) 
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Appendix 1: Effects of salicylate binding to A. niger 767 (A) and A. niger 577 (B) on the 
respective protein fluorescence spectra where λex= 450 nm.  Successive additions of salicylate 
were made to 50 mM Tris-HCl pH 7.6 buffer containing enzyme (5 μM) at ambient temperature.  
For clarity, not all salicylate concentrations used are shown.  
 
Appendix 2: Protein standards calibration proteins run on a Superdex 200 10/300 GL. Protein 
standards used are thyroglobulin (670 kDa), γ-globulin (158kDa), ovalbumin (44kDa) and, 
myoglobin (17 kDa).  The equation of the fitted line was -0.5368x + 3.2710 with an R
2
















Appendix 3: Gel filtration profiles of A. niger purified enzymes; 767 (A); 577 (B); 534 (C); 999 
(D); and 716 (E).  Samples were loaded on a Superdex 200 10/300 GL column connected to a 
BioRad BioLogic DuoFlow HPLC.  Proteins were eluted using  50 mM Tris-HCl, 100 mM NaCl 




Appendix 4:  Metal calibration standards for ICP-MS.  Sample above are: Mg (A); Ca (B); Mn 
(C); Fe (D); Co (E); Ni (F); Cu (G); and Zn (H). Standards were run by Alain Tessier on the LC-
ICP-MS (Agilent 7500ce) 
 
